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5,7-DHT 5,7-dihydroxytryptamine
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AMPA alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
BDNF brain-derived neurotrophic factor
BrdU bromodeoxyuridine
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Flk-1 fetal liver kinase-1
GABA gamma-amino butyric acid
GCL granule cell layer
hr hour(s)
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ICV intracerebroventricular
IGF-1 insulin-like growth factor-1
KA kainate
LC locus coeruleus
LV lateral ventricle
MCL mitral cell layer
min minute
ML molecular layer
NET norepinephrine transporter
NeuN neuronal nuclear antigen
NMDA N-methyl-D-aspartate
9NSE neuronal specific enolase
NT-3 neurotrophin-3
OB olfactory bulb
ON over night
PB phosphate buffer
PBS phosphate buffered saline
PCNA proliferating cell nuclear antigen
PCPA p-chlorophenylalanine
PFA paraformaldehyde
PGL periglomerular layer
PI propidium iodide
PSA-NCAM polysialylated neural cell adhesion molecule
Rb retinoblastoma gene
RECA rat endothelial cell antigen
RHOX rhodamineX
RMS rostral migratory stream
RT room temperature
SGZ subgranular zone
SVZ subventricular zone
TBS tris buffered saline
TGF-ß tumor growth factor-ß
TH tyrosine hydroxylase
TUC-4 TOAD (turned on after division)/Ulip/CRMP
TUNEL terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling
TX100 triton-X100
VEGF vascular endothelial growth factor
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INTRODUCTION
Generation of new neurons in the adult mammalian brain
The discovery that stem, or progenitor, cell populations produce neurons in the
adult brain highlights the dynamics of a previously assumed “static” organ.  During
development, all organs are created from groups of proliferating cells, which have the
potential to differentiate into those cell types that are needed for a functional organ.  In
adult tissues, these organ-specific stem cells are thought to play a major role in
replacement of cells lost to physiological wear and injury1-3.  The existence of neural
progenitor cells in the adult central nervous system (CNS) is therefore seen as a
paradox, since the brain has classically been thought of as a structure with very limited
regenerative capacity.  Nevertheless, in recent years, it became evident that the adult
brain is generating certain neuronal populations through a process termed “adult
neurogenesis”.
As early as 1912, scientists have noted mitotic activity in the cells of the lateral
ventricle of the adult rat4.  And although Altman proposed the concept of persistent
neurogenesis in the adult rodent brain as early as 19655, the neuroscience community
was hesitant to recognize the importance of this observation until 1977 when Kaplan
and Hinds were able to confirm, through the use of electron microscopy and 3H-
thymidine labeling, the neuronal fate of newly generated cells in the dentate gyrus (DG)
and subventricular zone (SVZ)/olfactory bulb (OB)6.  Through the use of better labeling
methods for newborn cells, it is now generally accepted that the DG of the hippocampus
and the OB are the two main areas of adult neurogenesis in the rodent.
The fact that new neurons are generated in the adult mammalian CNS has major
implications for the study of the brain’s regenerative capacity. (1) Neural plasticity is not
restricted to axonal sprouting and synaptic remodeling. The possibility of addition or
replacement of neurons could provide a fundamentally new approach to compensate for
neuronal loss during aging and after injury or disease. (2) The existence of multipotent
progenitor cells in the adult brain provides the possibility to study their functional
behavior either in vivo or after isolation in vitro. This allows new insights into important
concepts of progenitor cell biology, such as self-renewal, multipotentiality, lineage-
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commitment and differentiation. Moreover, strategies using these cells as autologous
sources for the therapy of neurodegenerative diseases can be developed. (3) Signals,
which are necessary to generate neurons from undifferentiated cells, are present in
certain regions of the adult brain. The special microenvironment that makes a region
neurogenic provides molecular signals required for each step of the generation of new
neurons. In order to make therapeutic use of neurogenesis it is important to know the
sequence of events and signals that lead to continuous neuronal replacement. These
signals could be used to induce neurogenesis of other neuronal populations that
undergo neurodegeneration.
Subventricular Zone/Olfactory Bulb Neurogenesis
The newborn neurons that are generated in the OB originate from the
subventricular zone (SVZ) of the lateral ventricle (LV). The SVZ is seen as a residual
proliferative matrix left over from the embryonic neural tube, which harbors rapidly
dividing neural progenitor cells.  In the adult, the progeny of the proliferating SVZ cells
migrate through the so-called “rostral migratory stream” (RMS) and proceed to the OB
(Figure 1B). It is important to note that two neuronal phenotypes are generated in the
OB, GABAergic granule cells (Figure 1D), which represent the majority (99%) of the new
OB neurons, and 1% dopaminergic periglomerular interneurons (Figure 1E)7-9.
Figure 1
Neurogenesis in the adult olfactory bulb (OB) is initiated by proliferation in the subventricular zone (SVZ) of the lateral
ventricle (left).  The newly formed cells (green – BrdU labeling) migrate through the rostral migratory stream (RMS)
and into the olfactory bulb, where they differentiate into two different neuronal types: 1 – periglomerular dopaminergic
interneurons (yellow, upper right), and 2 – GABAergic granular neurons (yellow, lower right).
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The olfactory granule cells are inhibitory interneurons that make their dendritic
connections to the mitral cells (MCL) and to the middle tufted cells (see Figure 2 to
illustrate the connectivity in the OB).  The periglomerular neurons project their dendrites
into the corresponding glomerulum and connect to the incoming olfactory axons from the
sensory epithelium; however, their axons project to mitral cells that reach into the
glomerular layer.  Recently, it has been shown that these newly formed neurons are
functionally integrated into the synaptic circuitry of the OB10 and there are implications
that olfactory interneurons may be important for maternal behavior, such as adaptive
behaviors in mating and pregnancy11.  In addition, data supporting the functional
integration of newly generated neurons have shown that sensory deprivation, by
plugging one nostril in the rat, downregulates neurogenesis in the ipsilateral GCL12.
Once the nasal plug is removed, the level of neurogenesis returns to normal13 indicating
an involvement of neurogenesis in olfactory functioning.
Figure 2
Depiction of olfactory bulb connectivity.  Periglomerular (PG) neurons (green cell) reside in the periglomerular layer
(PGL), make dendritic connections in the olfactory nerve layer (ONL) and project their axons to mitral cells (M1) that
reside in the mitral cell layer (MCL).  Mitral tufted cells (Tm) reside in the external plexiform layer (EPL) and project
their dendrites into glomeruli of the PGL, while their axons make connections with the granule cells (GS/GD) of the
granule cell layer (GCL).  The excitatory superficial and deep granule cells make their dendritic connections with the
tufted mitral cells in the EPL and the mitral cells of the MCL, respectively (adapted from Shepherd and Greer14).
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Hippocampal Neurogenesis
In the hippocampus, a structure involved in the processing and storage of new
information, progenitor cells are born along the thin border between the granule cell
layer (GCL) and the hilus, termed the subgranular zone (see Figure 3 for anatomical
details).  After cell division neuroblasts disperse along the subgranular zone and migrate
a short distance into the GCL along the processes of existing neurons and radial glia like
cells15.  The newly formed cells take on the morphology and immunohistochemical
properties of granule cells and express the granule cell marker Calbindin and neuronal
markers, such as NeuN (a pan-neuronal marker) and NSE, and to a very small degree
S100ß (a calcium binding protein and astrocyte-specific marker)16-18.
Figure 3
Neurogenesis in the adult hippocampus.  Proliferation of progenitor cells is detected in the subgranular zone (border
between granule cell layer, g and the hilar region, h) through BrdU labeling (1 day – bottom left).  Notice the clumps
of proliferating cells that can be up to 100 cells (bottom left), which within the first week after BrdU labeling (bottom
middle) begin to redistribute along the subgranular zone and later (bottom right) migrate into the granule cell layer.  In
the following weeks the newly formed cells differentiate into granular neurons and begin to express neuronal markers,
such as NeuN (red, top right) and Calbindin (picture modified from19).
These newly formed neurons, like all other granule cells of the DG, project their
axons to the CA3 region, form synaptical connections and are not electrophysiologically
discernible from the other granule cells 10, 20-23.  As the axons migrate through the GCL
to make their connections within the hilus and CA3 region, they interact with projections
within the SGZ and hilus of axons originating from the dorsal raphe (serotonergic) and
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the locus coeruleus (noradrenergic).  As the dendrites proceed through the molecular
layer, they receive synaptic input from axons coming from the entorhinal cortex
(glutamatergic) and the medial septum (cholinergic) via the perforant path and fimbria-
fornix, respectively (Figure 4).
Figure 4
Depiction of neurotransmitter connectivity in the dentate gyrus.  The granule cells residing the granule cells layer
(GCL) project their axons to the CA3 regions and make their dendritic connections within the molecular layer (ML).
Studies using retrograde and anterograde labeling, as well as long-term
potentiation have postulated the functional integration of adult generated granule cells
into the hippocampal circuitry.  Recently, electrophysiological and viral-labeling studies
confirmed that adult born granule cells have functional synapses and are
indistinguishable from their neighbors generated during early development20-22, 24.
The capacity for the adult brain to generate new neurons within these neurogenic
regions is immense.  For example, it has been estimated, through BrdU labeling
strategies, that several thousand new cells are born every day within the DG of the rat25.
This number of new granule neurons generated each month represents 6% of the total
population of the granule cells (between 1 and 2 million)26.  These numbers, together
with indications of physiological integration, would suggest that the newly formed
neurons very likely play an important functional role in the hippocampus27.  Within the
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olfactory system neurogenesis occurs at a magnitude higher than in the hippocampus.
Quantitatively, in rats it was estimated that at least 30,000 new neurons per day reach
the OB and these are capable of forming functional connections and fully integrating into
the existing circuitry (Figure 5).
Figure 5
Neurogenesis in the adult olfactory bulb. Animals received BrdU injections on 12 consecutive days and were analyzed
four weeks later. (A,B) A representative sagittal section reveals the high density of BrdU-positive cells in the olfactory
bulb. All labeled cells seen in the olfactory bulb migrated from the SVZ, since the bulb is free of BrdU-positive cells
immediately after labeling (data not shown). (B) Enlarged frame from (A). (C,D) Double labeling of BrdU-positive cells
with neuronal and glial markers. Antibodies against NeuN (red) and S100ß (blue) and were combined with anti-BrdU
(green) to detect neurogenesis in (C) the olfactory granule cell layer – OB and (D) the granule cell layer of the dentate
gyrus – DG. Arrows point out cells that are double-positive for BrdU and NeuN and represent newborn neurons. For
quantification of double-labeling see Table 1. Scale bars in (C,D) 20 µm. (Adapted from28)
Developmental Aspects of Adult Neurogenesis
During development the SVZ forms adjacent to the ventricle zone (VZ) and is most
prominent in the ganglionic eminences29 (Figure 6).  Later in embryonic development the
SVZ generates cells for the diencephalon30 and cortex31, 32, as well as for the adjacent
basal ganglia.  The cell types and lineage-relationships of the embryonic SVZ are not
fully understood; however, the location and proliferative activity of the adult SVZ suggest
that it is derived from the embryonic SVZ of the lateral ganglionic eminence33.  It has not
yet been shown conclusively as to whether the progenitors in the embryonic SVZ are
equivalent to those in the adult SVZ.
16
Figure 6
(A) Coronal section through the embryonic mouse forebrain at day 15 post conception.  The proliferative ventricular
zone (VZ) lines the lateral ventricles.  A secondary proliferative region, the subventricular zone (SVZ), is prominent in
lateral and medial ganglionic eminences (LGE and MGE) and transiently appears under the VZ of developing
neocortex (CTX).  (B) Coronal section through the adult mouse telecephalon.  Embryonic VZ is transformed into a
terminally differentiated ependymal layer lining brain ventricles.  Proliferative SVZ remains adjacent to the ependymal
layer of the lateral walls of the lateral ventricles.  This region is thought to be derived from SVZ of lateral ganglionic
eminence (A).  CTX = neocortex; CC = corpus callosum; STR = striatum.  (Modified after Garcia-Verdugo, et al.33)
During hippocampal development, the granule cell is the neuronal cell type that is
last to be born and in rodents, after birth, is generated from a secondary germinal matrix
in the hilus region34, 35 .  It seems that this matrix is capable of sustaining the viability of
undifferentiated cells, therefore creating the basis for continued neurogenesis in this
region. In the adult, the secondary germinal matrix is refined to a small band along the
border between the hilus and the GCL, termed the “subgranular zone”35. Here, the
progeny of proliferating progenitors migrate locally to differentiate into neurons of the
dentate GCL.
Neurogenesis in the adult brain appears to be a continuation of early postnatal
neuronal production, as there is no onset of adult neurogenesis, but persisting
neurogenesis that started during embryonic phases. In this sense, the development or
continued maintenance of such structures as the OB or the DG never ends, since
neurogenesis can be observed into very late stages of life19, even in primates and
humans36, 37; however, in both rodents and macaque monkeys, cell production in the DG
has been shown to decline with age19, 36. Nevertheless, neurogenesis is still detectable
in very old age, which opens the possibility of enhancing neurogenesis in the aged brain
to study changes in the age-related decline in hippocampus-dependent learning38.
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Phylogenetic Aspects of Adult Neurogenesis
Species shown to have neurogenesis
Invertebrates Several specials of Orthoptera and Coleoptera, milkweed bug,
cockroach, cricket, darkling beetle, lady bird, decapod
crustaceans (crayfish, shore crab, lobster)
Non-mammalian
vertebrates
Goldfish, zebrafish, gymnotiform fish, frog, lizard, turtle, canary,
songbird, chickadee
Mammalian
vertebrates
Mouse, rat, gerbil, guinea pig, squirrel, vole, pig
Humans and
primates
Tree shrew, marmoset, macaque monkey, human
Invertebrates
In invertebrates, persistent neurogenesis has been shown to occur in the
mushroom bodies of the insect brain, which are brain structures involved in learning and
memory and considered as functional analogues of the hippocampus39-42.  In decapod
crustaceans, neurogenesis occurs among the different neuronal types of the central
olfactory pathway throughout adult life, suggesting structural plasticity of the brain
circuitry43-45.  In addition, it has been shown that adult crickets, which are introduced into
an enriched sensory and social environment, have an increased neuroblast proliferation
and neuronal numbers in the mushroom bodies46.  However, neurogenesis was not
found in the adult brain of the honeybee47, the fruitfly48, the monarch butterfly49 or the
migratory locust50.
It is not exactly certain why neurogenesis persists in some insect species and not
in others.  To use phylogenesis as a criterion is not sufficient, since adult locusts, which
are phylogenetically close to crickets, do not maintain proliferating neuroblasts, whereas
some species, which are evolutionarily farther removed, such as Tenebrio (meal-worm
or darkling beetle) or Harmonia (lady bird), have adult neurogenic patterns similar to
crickets.
Non-mammalian vertebrates
Adult neurogenesis has also been shown to occur in non-mammalian vertebrates,
such as fish, frogs, lizards, turtles and birds51-53.  Neuronal recruitment occurs widely
throughout the adult songbird brain54, but has been studied best in the telencephalic
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high vocal center (HVC) and adjacent mediocaudal neostriatum53, 55.  In both cases, the
extent of ongoing neuronal recruitment is extraordinary: the adult canary HVC alone
recruits over 1.4% of its neurons daily56, 57.  Within this model, it has been established
that neurogenesis varies dramatically with seasonal changes in song production58, 59. In
chickadees, the learning behavior related to finding stored food is also correlated with
seasonal adult neurogenesis 60.
Fish, in particular, have exceptional abilities to regenerate parts of their CNS after
injury and experimental insult61, 62.  As is seen in mammalian systems, neurogenesis in
the adult teleost CNS appears to be restricted to specific proliferative zones.  These
regions in the adult forebrain have been reported in zebra fish63, 64, goldfish65, and
gymnotiform fish51.
In the adult frog, new cells are continuously generated in the preoptic recess
ventricular zone. From here, they are recruited to the hypothalamic preoptic nucleus66.
In both the lizard and turtle telecephalon, postnatal neurogenesis is also observed, with
an intense production of neurons in the medial cortex of the lizard, which has homology
with the hippocampal DG of mammals67, 68.  The ependymal cell layer underlying the
medial cortex retains its proliferative properties in adulthood and continues to produce
new cells69.  The lizard OB and nucleus sphericus are two other telencephalic regions
that also undergo adult neurogenesis70, 71.
Mammals
Discovered initially in rodents, adult neurogenesis has been demonstrated to occur
in the brains of all vertebrate species investigated thus far5, 36, 53, 67, 72-77, including
humans37, suggesting that it is both a primeval and a highly conserved process.
Although early attempts to detect neurogenesis in adult primates were hampered by
insensitive detection methods78 or difficulties with the methods used, several reports
now demonstrate that neurogenesis continues in the primate dentate36, 73, 74 and
possibly in other areas, such as the neocortex and the amygdala79, 80.  In addition, it has
been shown in the primate that the newly generated cells in the SVZ are capable of
migrating a remarkably long distance (several centimeters) to reach the OB81.
Work with terminally ill patients has recently confirmed that humans also generate
new neurons. The proliferation marker bromodeoxyuridine (BrdU) was injected into
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patients to monitor tumor cell proliferation.  Some of these individuals subsequently died
from their illness and the hippocampi were evaluated for the presence of BrdU-labeled
neurons.  Since BrdU was systemically administered, all dividing cells had been labeled
and, indeed, newborn neurons were detected in the GCL of all individuals ranging up to
more than 70 years of age37.
In summary, adult neurogenesis is a common phenomenon among lower
vertebrates, where continuing growth of neural structures as well as complete repair
after neuronal damage can be observed. In mammals, the extent and regions of
neurogenesis appear to be more restricted, although it is still detectable in the DG of the
human brain.  Nevertheless, in the invertebrate nervous system large species
differences occur.
Fundamentals of Adult Neurogenesis
In order to experimentally modify adult neurogenesis, it is necessary to separate
the mechanism into the crucial components. Neurogenesis is often thought of only in
terms of progenitor proliferation; however it encompasses progenitor proliferation as well
as fate determination (in the case of multipotent cells), migration, and differentiation into
fully mature neurons. Moreover, as will be described in more detail below, the outcome
of adult neurogenesis is also largely dependent on the capability of the immature
neurons to survive and not succumb to cell death.
1) Proliferation
2) Migration
3) Differentiation
4) Survival
Accordingly, just because proliferation is increased or decreased under certain
conditions, it does not necessarily mean that, as a consequence, the number of neurons
has increased or decreased. The migration of these cells can also be influenced,
thereby producing an effect in the target area or in the area that the proliferating cells
migrated to.  A change in the fate of a cell is also crucial when one thinks about
regulating neurogenesis.  If a pool of cells that were originally destined to become
neurons is suddenly persuaded to become astrocytes (or vice versa), this can have
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detrimental effects.  Last, and certainly not least, the survival or proper elimination of
these newly formed neurons is also crucial to the overall outcome.
With tens of thousands of neurons being born every day in the adult rodent brain, it
becomes apparent that cells must also be lost to maintain the brain within the limited
confines of the skull.  Although it was shown in the 80’s that the total number of granule
cells in the hippocampus and OB continue to increase throughout the lifetime of the rat16,
82, the numbers are nowhere near the numbers calculated from proliferative data (Figure
7). This has led to the assumption that an elimination process removes surplus cells.
Dentate gyrus - actual
Dentate gyrus - theoretical
Olfactory bulb - actual
Olfactory bulb - theoretical
0
5000000
10000000
15000000
20000000
25000000
30000000
Theoretical vs. Actual Growth of Neurogenic 
Regions
Figure 7
From Bayer and Kaplan studies it is known that the number of granule cells in the dentate
gyrus and the OB continually increase over the first year of the rat’s adult life (real growth16,
83).  However, one can estimate from the proliferation data a much higher growth
(calculated), which suggests a possible elimination mechanism through cell death that
regulates the actual numbers.
Work done in collaboration with Manfred Biebl has shown programmed cell death
in adult brain regions with known neurogenic activity28. Other reports have confirmed
that neuronal progenitor cells are eliminated in the postnatal and adult SVZ and RMS84-
86. Our stereological assessment, however, emphasized that the elimination of cells
occurs in a caudal to rostral gradient of apoptotic cells, with an increasing number of
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TUNEL-positive cells towards the OB.  More importantly, our work reveals that areas of
adult neurogenesis contain up to 100 times more apoptotic cells than non-neurogenic
regions.  Since about 80% of these cells were actually localized in the olfactory GCL, it
was concluded that a large proportion of cells generated in the SVZ are eliminated after
reaching their target area, the OB.
When analyzing neurogenesis and programmed cell death in the DG, a similar
ratio of BrdU-positive to TUNEL-positive cells was detected in the GCL. The majority of
dying cells was found at the border between the hilus and GCL, again suggesting that
elimination of cells occurs primarily in the neurogenic region of the DG87.  Taken
together, these data indicate that programmed cell death has an important regulatory
function by eliminating supernumerous cells from neurogenic regions and thus
contributes to a self-renewal mechanism in the adult mammalian brain.
In order to understand whether the newly formed cells or the already existing
neurons are eliminated, another study was performed in our lab in collaboration with
Beate Winner9.  Adult rats were injected with BrdU and a time-course analysis was
carried out.  At specific time points after BrdU injection, the rate of the loss of BrdU-
positive cells in the OB was measured.  It turns out that approximately 50% of newly
formed BrdU-positive cells are eliminated within the first 3 mos.  However, newly formed
neurons that survive this elimination phase are detectable for the rest of the lifetime of
the rat, or at least to the last time point measured (19 months) (Figure 8).  From these
results, it can be concluded that progenitor cells and young neurons are the ones being
eliminated. This mechanism mirrors the embryonic brain development, where
approximately 50% of the neurons are overproduced and eventually eliminated through
programmed cell death88.
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Figure 8
Time course analysis of the total number of newly generated cells and new neurons in the olfactory bulb
granule cell and glomerular layer. The total number of BrdU immunopositive cells (squares) per region
was determined over a period of 19 months after BrdU injection in (A) the granule cell layer and (B) the
glomerular layer. The percentage of new neurons (rhombus) was determined by confocal microscopy as
the number of BrdU-positive cells that co-expressed the neuronal marker NeuN. Neuronal cell numbers
were determined by multiplying neuronal percentages with the total number of BrdU-positive cells. The
data are presented as the mean number of BrdU-positive and BrdU/NeuN double positive cells per region
± S.E.M. for each time point post BrdU injection (n = 6 - 8 per group) (Adapted from Winner, et al9.
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Regulating Adult Neurogenesis: Which Stimuli Make a Difference?
The scope of this dissertation is to define more precisely the mechanisms and
signals that influence adult neurogenesis in order to better understand why and how it
occurs and to possibly make use of neurogenesis as a neuroregenerative tool. At the
onset of this dissertation in 1998-1999, relatively little was known regarding the factors
that control the generation of new neurons, however the knowledge has dramatically
increased since then. The following chapter will mostly describe the relevant work that
was published before 1999 and led to the design of the experimental studies described
below. The Discussion section that follows the Experiments gives a more detailed
overview of more recent developments in the field in relation to the findings of these
experiments (see especially the comprehensive table of neurogenic factors in
Appendix).
Systemic Influences:
Age
The very first neurogenesis studies showed that the production of new nerve cells
didn’t end in the early postnatal period, but was rather a continual process89.  Since
then, it has been shown that neurogenesis in the hippocampus decreases with age;
although even in very old animals, there remains a low-level of neurogenesis19, 38.  It
could be shown that a decrease in the proliferation of neuronal progenitors was
responsible for the decrease in neurogenesis, whereas the proliferation of other cells,
such as astrocytes in neighboring regions, remained unchanged19.
Environment (sensory stimulation)
"Enriched environment" paradigms, where animals are placed into housing
conditions that are more similar to their natural surrounding, have been shown to
increase neurogenesis38, 90-92.  The enriched environment seems to be neuroprotective
for young neurons that would otherwise be eliminated by apoptosis under standard
laboratory conditions93.  The "enriched" animals also showed improved motor skills and
better performance in learning tasks91. Most importantly, the stimulatory effect on
neurogenesis occurred at all ages, including senescence, even when the animals were
24
housed under enriched conditions for only a few weeks38. The unique capability of
regulating the production of new neurons in a structure so closely associated with
acquisition of new information suggests a possible function for newly generated neurons
in certain types of learning.
In the OB, sensory deprivation attained through a “nasal plug” leads to a
decrease in neurogenesis in the GCL12.  However, when rats were challenged daily with
different scents, it was shown that not only did neurogenesis increase in the OB, but the
rats also became better at olfactory discrimination tasks, whereby the hippocampal
neurogenesis and hippocampus-dependent learning remained unchanged94.  In
addition, olfactory synaptic circuitry seems to be important for adaptive behaviors during
mating and pregnancy11.  It appears that neurogenesis in the adult brain reacts
specifically and regionally to different sensory modalities.
Activity (physical exercise)
Among the stimulatory factors within an enriched environment, voluntary physical
activity appears to be a very strong activator for the proliferation of hippocampal
progenitor cells95, 96. The sole introduction of a running wheel into a standard laboratory
cage doubled hippocampal neurogenesis, suggesting that cerebrovascular parameters,
such as blood flow, glucose uptake, and neovascularization could be mediators of this
effect97.  In fact, one study has shown that the exercise-induced increase in
neurogenesis is dependent on the uptake of blood-borne insulin-like growth factor-1
(IGF-1)98.  These results underline the truth in the ancient Latin proverb "Mens sana in
corpore sano" (Roman poet Juvenal)- “a sound mind in a sound body”. Rehabilitation
strategies for stroke or trauma patients emphasizing a multitude of sensory stimuli,
motor tasks and complex training situations have long incorporated the concept of
stimulatory effects from an enriched environment.
Stress
Environmental signals can also be detrimental to neurogenesis. Stressful
experiences are known to activate the hypothalamic-pituitary adrenal (HPA) axis and
increase levels of circulating adrenal steroids. Several different types of stressful
experiences, such as exposure to predator odor, subordination stress, acute
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psychosocial stress and resident-intruder stress, have been shown to inhibit granule cell
production in the DG of rats, tree shrews and marmoset monkeys72, 73, 99-103.  It is likely
that the changes in granule cell genesis are the result of stress-induced activation of the
HPA axis and ultimately elevations in glucocorticoid levels, since reducing corticosteroid
levels in aged rats restores the rate of cell proliferation, resulting in an increased number
of new granule neurons104, 105. But not only stressful experiences in adulthood influence
proliferation and survival of neurons in the differentiated mammalian brain. Prenatal
stress in rhesus monkeys and female rats has also been shown to induce a reduction in
neurogenesis in the DG throughout life106, 107.
Extracellular cues:
Hormones
Glucocorticoid hormones, such as cortisol and corticosterone secreted by the
adrenal cortex, have been shown to inhibit the production of new granule neurons by
suppressing the proliferation of granule cell precursors104, 108, as well as the number of
newly formed neurons in the DG109. On the other hand, removal of circulating
glucocorticoids by adrenalectomy results in a clear increase in progenitors in the DG of
young adult rats104, 105, 108.
Growth Factors
Although some of these neuromodulatory signals trigger proliferation, the direct
mitogenic stimulus to the progenitor cells appears to be mediated via growth factors.
From in vitro data, it was already known that basic fibroblast growth factor (FGF-2) or
epidermal growth factor (EGF) are required to keep neural progenitor cells in an
undifferentiated and proliferative state110, 111.  Therefore, it was consequential that these
growth factors would be the first ones to be tested in vivo as well.  Dentate precursor
cells are known to express EGF receptors and direct infusion of the growth factor into
the DG stimulates proliferation112. Chronic infusion of EGF and FGF-2 in the ventricular
system of adult rats, however, triggered proliferation predominantly in the SVZ, but was
nearly ineffective in stimulating proliferation in the subgranular zone18. In adult mice, the
same effects were seen in the SVZ when EGF was infused into the LV113.
Nevertheless, when using this route of administration, EGF induced a prominent
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phenotypic shift leading to more astrocytes and fewer neurons in the OB and DG18. Via
peripheral application, selective induction of neurogenesis has also been achieved using
FGF-2114 or IGF-1115.
Interestingly, it has been shown that not only does neurogenesis in the DG
decrease with age19, but serum IGF-1 levels also decrease.  When aged rats were
infused with IGF-1 into the LV, neurogenesis levels were restored by almost 3-fold116.
These data suggest that IGF-1 may be an important regulator of neurogenesis in the
aging hippocampus and that an age-related decline in IGF-1-dependent neurogenesis
could contribute to age-related cognitive changes.
Neurotransmitters
Recent evidence supports the view that neurotransmitter systems could influence
the production of new granule neurons in the DG. The glutamate system is probably the
most studied neurotransmitter system when it comes to neurotransmitters and their role
in neurogenesis.
Lesioning of the entorhinal cortex, the major glutamatergic input into the
hippocampus, has been another model to show glutamate’s role on hippocampal
neurogenesis.  When the entorhinal cortex was unilaterally lesioned with ibotenic acid,
thereby destroying cells through an excitotoxic mechanism, an increase in proliferation
in the DG was observed117.  This study suggests that glutamatergic input to the DG via
the perforant path appears to suppress the proliferation of granule cell precursors.
However, this study was lacking the phenotypical analysis of newborn cells, which
leaves the question open as to whether the increased proliferation detected led to an
actual increase in newly born neurons.
There have been several studies performed examining the role of glutamate
receptors.  It was observed that proliferation in the GCL was significantly decreased
following treatment with NMDA117.  In addition, NMDA is capable of blocking the
increase in hippocampal proliferation after adrenalectomy118. Conversely, adult rats
were also injected with glutamate antagonists117-120 .  All of these compounds have been
shown to increase the number of proliferating cells in the DG, either in rat, gerbil or tree
shrew72, 120, 121.  Moreover, these compounds were also able to increase the number of
new neurons in the DG117, 119, 120.
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OVERALL GOAL
Taking these findings together, several influences with high complexity such as
environmental stimulation, physical exercise, stress and aging have an impact on
neurogenesis. However, the underlying molecular basis for these regulatory
mechanisms are not well understood.  It was, therefore, the goal of this study to broaden
the current knowledge especially by focusing on molecular signals that may regulate
neurogenesis. This dissertation concentrates on the analysis of three separate classes
of molecules:
(1) transcription factors
(2) neurotransmitters
(3) growth factors
Their possible function during adult neurogenesis was analyzed using three
methodological approaches:
(1) knockout strategy
(2) intraventricular infusion
(3) neurochemical lesion
Thus, the aims were not only to characterize different molecular targets but also to
compare different intervention strategies for adult neurogenesis.
SPECIFIC AIMS
In order to analyze neurogenesis, histological methods have been developed
based on the use of a thymidine-analogue for labeling of dividing cells. However, there
has been an ongoing debate over whether bromodeoxyuridine (BrdU) is an appropriate
marker to be used, in combination with neuronal markers and confocal analysis, for the
unequivocal detection of new neurons. It was unclear whether in BrdU-labeling
approaches, BrdU is marking DNA repair as well. Clarifying this issue and providing a
methodological basis for the subsequent experiments was crucial and lays the
foundation for the subsequent experiment - Experiment I.
Many of the growth factors, which have been shown to upregulate neurogenesis,
activate a chain of events through several signaling cascades that eventually lead to the
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specific targeting of transcription factors.  In Experiment II, I was interested in
evaluating what the possible role of the transcription factor E2F1, a member of the E2F
family of cell cycle control genes, could be in regulating adult neurogenesis. The primary
aim was to study the effect of E2F1-deficiency on adult neural progenitor cells by
performing stereological analyses on the progenitor proliferation in the DG and SVZ, and
the resulting generation of new neurons.  Finally, because E2F1 has been reported to
be involved in cell death of postmitotic cells, I also wanted to determine the frequency of
apoptotic cells in the regions of adult neurogenesis.
Experiments III & IV were aimed at identifying the role of neurotransmitter input on
adult neurogenesis.  In these experiments, the cholinergic and noradrenergic inputs into
the hippocampus and OB were selectively lesioned through the use of transmitter-
specific neurotoxins and it was our objective to investigate the effect of these selective
denervations on neuronal differentiation and survival in the DG and OB.
Since it is known that an increase in neurogenesis is one of the responses to a
diseased state such as hypoxia, I wanted to ask the question of whether or not vascular
endothelial growth factor (VEGF), which is upregulated during hypoxia or ischemia, is
capable of stimulating neurogenesis.  In Experiment V, the effects of VEGF on
proliferation and survival of neural progenitor cells in the DG of the hippocampus and
the SVZ/OB system were investigated through the use of intracerebroventricular (ICV)
injections.
As a continuation of Experiment I, I was interested in more precisely defining the
course of events during the formation of neurons in the adult brain. Experiment VI aims
at determining the time course of expression for several genes that are expressed
during the neuronal maturation process.  Knowing and understanding the specific
expression for certain genes during neurogenesis could afford a broader range of
markers for labeling newborn neurons.  The specific goal was to analyze the expression
of doublecortin (DCX) in the neurogenic regions of the adult brain, as well as to
determine whether DCX expression changes with age.
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EXPERIMENTS
This dissertation was designed to evaluate different influences on adult
neurogenesis. Consequently, the experimental data are presented as individual studies,
with separate introduction, result and discussion sections. At the end a General
Discussion section will put the data of all experiments into a common perspective. Since
the materials and methods used to detect and quantify neurogenesis are identical, they
are appended at the end of the thesis; whereas, only the specific details of the design of
each study are presented in the individual experiments. The first experiment represents
an exception to this general structure since it was designed to critically evaluate the
methodological basis for the following experiments. Therefore, in Experiment I, the data
are presented in the form of a review, and directly combined with a literature overview.
Experiment I - Critical evaluation of BrdU labeling
(Cooper-Kuhn, C. M. and Kuhn, H. G., 2002, Developmental Brain Research 134:13-21)
Objective
Since the early sixties, in vivo observations have shown the generation of new
neurons from dividing precursor cells. Nevertheless, these experiments suffered from
critique, suggesting that the prevailing labeling method, which incorporates tagged
thymidine analogs, such as 3H-thymidine or BrdU, may not be detecting a proliferative
event, but rather could mark DNA repair in postmitotic neurons. Even today many
scientists are still skeptical, because the question of specificity for thymidine labeling has
not been sufficiently answered. This first experiment aims at (1) presenting histological
evidence of specificity of BrdU labeling for neural progenitor cell activity in the adult
brain, (2) validating and comparing BrdU labeling with other histological methods, and
(3) combining BrdU and labeling methods for apoptosis to argue against DNA repair
being a major contribution of BrdU-positive cells.
Introduction to Experiment
As a prerequisite to studying progenitor cell activity in vivo, it is necessary to not
only identify proliferating cells, but to also stably label their progeny. BrdU labeling is
currently the prevailing method to study proliferation and neurogenesis in vivo122.
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Systemically injected BrdU is incorporated as a thymidine analog into the DNA of all
cells undergoing DNA synthesis, within the time that BrdU is present in the cellular
thymidine pool (for review see123-125).  BrdU integrates into the DNA during the DNA-
synthesis phase of the cell cycle and is passed on to the daughter cells. Once
incorporated into the DNA, BrdU can be detected immunohistologically in postmitotic
cells for the remainder of their life, unless the cells undergo consecutive proliferation,
which will exponentially dilute the BrdU signal in the nucleus126. If a cell becomes
postmitotic, the permanent BrdU label enables one to study the fate of newborn cells by
detecting it in combination with cellular markers for neuronal development, such as
neuron-specific proteins.  In a similar fashion, 3H-thymidine autoradiography was
previously used. After 3H-thymidine labeling of dividing cells, silver grains are created in
a photo emulsion that overlays the histological section. The histological evaluation is
burdened by a time-consuming exposure followed by the matching of silver grain signals
to the underlying cells. 3H-thymidine was successfully applied to initially detect neuro-
genesis in adult brain tissue before other histological markers were available5, 127, 128.
An alternative method to measure proliferative activity in vivo is the detection of
mitotic markers, such as PCNA (proliferating cell nuclear antigen – a protein expressed
in S and late G1 phase) and Ki-67 (a protein expressed throughout the cell cycle).
Although excellent markers for proliferating cells, these markers are not suitable for
detecting the neuronal progeny of dividing cells, since by the time a cell expresses
mature neuronal markers, it has already left the cell cycle. Retroviral labeling appears to
be the only other alternative method for detecting neurogenesis, because for successful
retroviral labeling, a cell must go through complete cell division.  Retrovirally labeled
cells will pass on the retroviral genome to their progeny and will continue to express a
reporter gene even after neuronal maturation129, 130.
Although widely used to detect in vivo neurogenesis, labeling with thymidine
analogs is not free of methodological problems. In order to address whether BrdU might
label cells undergoing DNA repair, as well as to demonstrate that BrdU-labeled cells
undergo a gradual development from a dividing progenitor cell to a mature neuron, the
co-localization of BrdU in a time series using markers for mitosis, progenitor cells, and
immature and mature neurons was analyzed.  Double-labeling data is also presented,
showing cell division and apoptosis, in order to determine whether BrdU is detectable in
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cells undergoing DNA repair in the final stages of apoptotic DNA degradation.  Finally,
we propose methodological standards for the detection and quantification of
neurogenesis in vivo, whether new regions or new species are proposed.
Experimental Design
For specific details on Experimental Design, see Materials and Methods on page 106.
Results and Discussion
Time course analysis of BrdU-labeled cells
Until the in vivo generation of neurons from dividing progenitor cells can be
followed directly through the use of time-lapse video microscopy, it is necessary to
detect adult neurogenesis histologically via markers that are incorporated during cell
division.  BrdU is incorporated into all cells undergoing cell division; however, two
additional sources of DNA incorporation are also possible: (a) mitochondrial DNA
synthesis and (b) DNA repair. Mitochondrial labeling can be excluded by verifying that
the BrdU signal is detectable within the nucleus, which can easily be accomplished with
confocal microscopy.  DNA repair is carried out by cellular enzyme complexes, which
secure the genomic stability of cells (for review see131, 132). DNA repair often occurs in
the CNS as an attempt to rescue postmitotic neurons after damage by irradiation or
mutation-inducing chemicals, although a high percentage of these cells will eventually
undergo cell death133-135.
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One attempt to determine specificity of BrdU labeling is to show the sequential co-
expression of markers for neuronal development at multiple time points after BrdU
labeling (see Figure 9 and Figure 10). It is difficult to argue that BrdU-labeled DNA repair
in mature neurons, if BrdU is first detected in immature dividing cells and only several
weeks later in mature neurons.
 (1) The cell cycle marker Ki-67, as well as other cell cycle markers 136, are only
detectable in BrdU-positive cells during the first days after labeling, when the cells are
still in S-phase. Moreover, mitotic figures have previously been described to be a
common phenomenon in brain regions with progenitor cell activity137, 138.
(2) While the progenitor marker, Nestin, co-labeled with BrdU within the first two
days after BrdU injection, markers for young neurons, ß-III-tubulin139, 140 and DCX141, 142,
were only transiently detected between 2 and 10 days after BrdU application.
(3) Finally, the mature neuronal marker NeuN143 was expressed after 10 days.
Since co-labeling of NeuN with BrdU was not shown within the first 2 days after BrdU
injection, it is unlikely that postmitotic neurons, which undergo DNA repair, are able to
incorporate detectable amounts of BrdU. These data argue strongly for a gradual
development of the BrdU-positive cells into neurons and are in disagreement with the
hypothesis that DNA repair mechanisms in damaged postmitotic neurons could be the
cause for BrdU signals in intact adult brain tissue.
Figure 9
Depiction of antibody expression pattern in relation to BrdU labeling.  Immediately after BrdU labeling, cells are
positive for Ki-67 and Nestin and these expressions taper off after 2 days.  By 2 days, expression of ß-III-Tubulin is
detectable and begins to taper off by 10 days, whereby DCX expression remains strong through 10 days and is no
longer detected at 4 weeks.  NeuN isn’t detectable until 10 days and remains strong throughout the life of a neuron.
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Figure 10
BrdU labeling in the adult dentate gyrus. At different time points after BrdU application (2 hrs, 2 days, 10
days and 4 weeks), co-labeling of BrdU with stage-specific markers reveals that newly generated cells
in the granule cell layer of the dentate gyrus undergo neuronal development. At 2 hrs and 2 days after
BrdU injection, most BrdU positive cells are still in cell cycle, as determined by Ki-67. At these time
points, some of the BrdU positive cells express the neural progenitor marker, Nestin, as well. It is
important to note that at later time points no co-labeling of BrdU-positive cells with Ki-67 or Nestin was
observed. ß-III-tubulin and DCX, which represent markers for immature neurons, both co-label
transiently with BrdU at 2 days and 10 days post BrdU application. Finally, NeuN, a marker for mature
neurons, labels only BrdU-positive cells after 10 days and later, which confirms that BrdU is not initially
(at 2 hrs) incorporated into mature neurons.
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Electron microscopy
Ultrastructural identification of mitotic precursor cells of the DG and the LV can
unequivocally distinguish between dividing cells and mature cells with DNA damage.
When combined with BrdU or 3H-thymidine labeling, electron microscopic reconstruction
provides powerful evidence that labeled cells are initially immature, dividing cells,
without signs of damage89, 137. At longer intervals after thymidine analog injection, the
labeled cells were characterized as young neurons or, after several weeks, as mature
neurons with synaptic connections6, 16, 144. The dividing cells in the SVZ appear to be
more immature and free of synapse-like structures, whereas the hippocampal progenitor
cells were described as “mitotic neuroblasts with synapses on their cell bodies and
processes which resemble axons”89. Taken together, electron microscopy studies
confirmed that 3H- thymidine-positive cells undergo development from immature
progenitors to mature neurons without signs of DNA damage - yet another argument
against DNA repair as a major source of thymidine labeling.
Retroviral labeling
Detection of newborn neurons using a retroviral construct 130, 145, 146 provides
several advantages compared to BrdU labeling.  (1) The stable integration of the
retroviral genome into the chromosomal DNA can only occur after nuclear membrane
breakdown. This ensures that an infected cell will stably express viral genes only when it
has undergone mitosis. Retroviral labeling, therefore, distinguishes between cell division
and DNA repair. (2) Since the viral DNA is integrated into the host genome, it will be
replicated and transmitted to every daughter cell. In comparison to incorporated
thymidine analogs, which are diluted during every new cell division and eventually lost if
a cell continually divides, retroviral labeling allows for the study of all progeny,
regardless of the number of divisions. (3) The introduction of reporter genes such as ß-
galactosidase147 or green fluorescent protein148, which freely distribute in the cytoplasm,
make not only the detection of newborn cells possible, but also the study of the cell
shape, including axonal and dendritic processes.
Retroviral labeling has been used to detect neurogenesis in the adult CNS84, 149-151.
It serves as a strong argument for the validity of studies using BrdU to detect
neurogenesis in the adult brain. Experiments with limited dilutions of retrovirus, which
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statistically produce only single infections, have indicated that cells act as multipotent
neural progenitor cells in the adult LV152.
But several disadvantages make retroviral infection less suitable for in vivo
applications: (1) Retrovirus particles have to be directly applied to the CNS region of
interest, since the blood-brain-barrier is an impermeable obstacle for the virus particles.
Stereotaxic injection of the virus, on the other hand, causes damage from the cannula
tract. Thus, when using retroviruses, possible lesion-induced effects on neurogenesis
have to be taken into account when studying progenitor cell activity in the intact brain.
(2) Biosafety and technical issues during generation and use of retrovirus particles, such
as helper virus-free preparations153, as well as titer and stability of virus particles154-156,
make the method more technically demanding and costly than BrdU labeling. (3)
Although all progeny of an infected cell will carry the retroviral genome, it is not
guaranteed that the reporter gene will be continually expressed in all cell types,
especially in the CNS, where shutdown of retroviral gene expression has been
observed157, 158. Nevertheless, positive signals, such as GFP, from retrovirally labeled
neurons are still the strongest argument for the occurrence of neurogenesis in the adult
brain.
BrdU, DNA repair and cell death
BrdU is incorporated into all cells during DNA synthesis, including those that
undergo DNA repair. Obviously, complete replication of the genome during cell division
will incorporate BrdU to a much higher extent than limited DNA repair, but it is unclear
whether the immunohistological BrdU signal can only be generated from cell division or
from DNA repair as well.
An experimental approach to determine the origin of BrdU signals is the induction
of DNA repair while BrdU is present. In response to ionizing radiation, cells immediately
activate DNA repair pathways, which detect and correct DNA damage, including
modified bases, sugar damage, strand breaks, and clustered DNA damage134, 135, 159, 160.
Base excision and nucleotide excision repair involve integration of new nucleotides and,
therefore, BrdU incorporation, whereas DNA strand breaks are corrected by DNA
ligase131, 132, 161. Ionizing radiation has been shown to dose-dependently increase DNA
damage followed by DNA repair, as well as cell death162. When the number of BrdU-
positive cells is measured in the LV after increasing doses of irradiation, a dose-
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dependent decline in proliferation and BrdU-labeling was found136, 163, 164, whereas the
number of apoptotic cells sharply increased165, 166. Although this experiment cannot
disprove that a small fraction of residual BrdU positive cells may still have undergone
DNA repair, it is unlikely that DNA repair represents a major source of BrdU labeling in
the LV.
To directly demonstrate whether cells can incorporate significant amounts of BrdU
during apoptosis, mice were injected with BrdU (50mg/kg) and perfused 2 hrs later.
BrdU labeling was then combined with two independent markers for apoptosis: active
caspase-3, which marks the final step in a protease cascade, and TUNEL (terminal
deoxynucleotidyltransferase-mediated dUTP nick-end labeling), which reveals the
resulting DNA degradation. Both apoptosis and cell division are found in the DG and the
LV28, but no BrdU-labeling was detected in cells positive for active caspase-3 or TUNEL
(Figure 11). Although DNA repair was not directly assessed in these experiments, the
data strongly argue that a standard dose of BrdU (50mg/kg bodyweight) injected into
adult rodents is not sufficient for detecting DNA repair during apoptosis.
Figure 11
Proliferation and apoptosis in the adult brain.  Both, cell division and apoptosis are occurring in the
dentate gyrus and the ventricle wall; however, when BrdU incorporation was analyzed in the
subventricular zone (SVZ) 2 hrs after systemic injection, no co-labeling with apoptotic markers, such as
active Caspase-3 and TUNEL, was observed. This confirms that the standard dose of BrdU used is
sufficient for labeling dividing cells. But BrdU it is not being incorporated into cells undergoing cell death,
although cell death may be accompanied by DNA repair.
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Requirements for detecting neurogenesis in new regions
Thus far, two regions of the adult brain have been unequivocally shown to
continuously produce new neurons, the LV/OB system and the DG. Neurogenesis was
verified in these regions with multiple methods, such as 3H-thymidine, BrdU, retroviral
labeling and electron microscopy, providing very strong arguments that adult
neurogenesis is not an artifact.  In vitro experiments, which showed the generation of
neural progenitor cell cultures from other sites in the adult brain, including spinal cord,
cerebral cortex and white matter tracts, suggest that progenitor cells are present
throughout the brain and therefore, adult neurogenesis might be a more common
phenomenon than currently assumed. Recently, first reports on spontaneous cortical
neurogenesis in the primate80 and lesion-induced cortical neurogenesis in the rat and
mouse141, 167 indicate that the current view of limited neurogenesis in the adult brain may
have to be revised.
It is very likely that novel brain sites with adult neurogenesis, such as the cerebral
cortex, will have rather limited amounts of newly generated cells. But in instances where
a low number of labeled cells are detected, the chances are higher that a substantial
quantity of these cells could be false positive.  In order to increase the confidence that
neurogenesis is a common phenomenon in several areas of the adult brain, the data
from the present experiment advocate the notion of using multiple histological criteria,
rather than relying exclusively on a single detection method.
Time course analysis. With the use of sequential markers for progenitor cells,
neuroblasts and mature neurons, BrdU can be co-labeled at different time points after
BrdU injection. This criterion assumes that each cell undergoes a sequence of steps
from a dividing progenitor to a fully mature neuron. The detection of these steps with
several immunohistochemical markers at multiple time points (Figure 10) would make a
strong case for neurogenesis in a novel region. Moreover, in case the place of origin
differs from the place of neuronal differentiation, it is of interest to find the migratory
route of the immature cells, which again is best shown in a time course investigation.
3D-confocal analysis. Individual BrdU positive cells should be systematically
analyzed by confocal microscopy in order to distinguish true co-labeling of BrdU with
neuronal markers from false-positive cells. Considering the risk that BrdU-positive
satellite glia cells, which can be very closely associated with cortical and striatal
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neurons, can mimic co-labeling in standard immunofluorescence analysis, confocal
analysis becomes an even more essential tool18.
Retroviral labeling. To unequivocally confirm neurogenesis in new areas, BrdU
labeling should be validated by a separate method as well. Due to the fact that retroviral
vectors can only integrate into the genome during cell division, successful retroviral
infection is currently the most convincing argument for the occurrence of adult
neurogenesis.
Electron microscopy. Ultrastructural analysis is extremely helpful in determining the
nature of labeled cells, in particular the cell type, as well as the differentiation state.
Moreover, electron microscopy is relying on structural criteria, rather than on
immunohistological markers, in order to determine cell types. Nevertheless, exhaustive
and quantitative analysis of large areas such as the neocortex at the ultrastructural level
are extremely time consuming.
Alternatives: Markers for cycling cells and young neurons
In some cases, systemic BrdU application and more invasive methods, such as
intracranial retrovirus injections, are not the most desirable procedures: (1) For the study
of neurogenesis in human subjects, ethical concerns will strictly limit the use of such
labeling techniques, especially if intended for research purposes. And only in very rare
cases, such as previous unrelated BrdU treatment for diagnostic reasons, is it possible
to obtain labeled human brain samples from autopsies. This was the case for the
pioneer study, which demonstrated ongoing neurogenesis in the hippocampus of adult
humans37. (2) Studies, which directly analyze the effects of altered stress levels on test
animals, will certainly have to take into account that invasive methods, such as repeated
peripheral injections, not to mention surgery, will alter the levels of stress hormones,
which, in turn, have been shown to regulate neurogenesis (for review see101). In these
instances, it might be desirable to use, for example, the oral application route for BrdU
via drinking water. Although this will allow for the detection of neurogenesis, the
quantitative analysis of oral BrdU application is hindered by the inability to control the
amount of BrdU uptake by individual experimental animals.
In experiments, where animals are studied in the wild, it may become necessary to
completely exclude any interference by the experimenter prior to the histological
analysis. In this case, it will be necessary to resort to cell cycle markers, such as Ki-67
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or PCNA, and markers that are only transiently expressed in young neurons. Especially
the markers for neuroblasts and young neurons, such as beta-III-tubulin139, 140, DCX141,
142, PSA-NCAM168, Hu169, 170, and TUC-4 (previously named TOAD-64171), could prove to
be extremely helpful, if they are truly specific for earlier stages in neuronal development
and are no longer expressed in fully mature neurons. It will be necessary to prove that
these markers have the assumed cell type and stage specificity in the particular species
of interest.
BrdU labeling: methodological considerations
BrdU is widely used for labeling newborn neurons in vivo, but several cautionary
observations for this technique must be discussed. BrdU is incorporated into the DNA as
a thymidine analog. But the size of the bromine atom can alter the DNA structurally, with
implications for the integrity and functionality of the DNA. It is, therefore, necessary to
reduce the concentration of injected BrdU to the minimal detectable dose.
Cytotoxicity. With the integration of a halogenated compound into the DNA, the
stability of the DNA can be drastically altered, increasing the risk of sister chromatin
exchange, mutations and DNA double-strand breaks172, 173. Given in higher doses during
embryonic development, BrdU can lead to teratogenic malformations and behavioral
changes174-176. Nevertheless, the use of systemic injections in adult rodents is most
commonly applied (50mg/kg bodyweight). When using higher doses or more continuous
labeling (e.g. via drinking water), one should take into account that mitotic cells are
sensitive to prolonged BrdU exposure and may react with altered gene expression or
cell death177. However, experimental data that are based on the comparison of BrdU
labeling between control and experimental animals should lead to valid information.
Diffusion barriers. Thymidine analogs given systemically will distribute throughout
the body and can readily cross the blood brain barrier in rodents. But 3H-thymidine
labeling was shown to be stronger after ICV, rather than intraperitoneal, injection. It is
also unclear what concentration is reached in the brain and whether the uptake into the
CNS differs between species. In the primate, it was assumed that the blood-brain-barrier
is not permeable and initial studies used ICV injection to demonstrate adult
neurogenesis178.  However, in later experiments, including the first study in humans,
intravenous BrdU application was equally successful.  Since intraventricular injection of
BrdU requires surgery, the systemic application is more commonly preferred. But when
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studying neurogenesis under pathological conditions, such as trauma or stroke, the
breakdown of the blood-brain-barrier after lesion may alter BrdU availability and may
change quantitative data when compared to unlesioned controls. Under these conditions
it is necessary to validate BrdU with independent markers for progenitor cell proliferation
and neurogenesis, such as Ki-67, DCX or ß-III-tubulin.
Summary
The detection of in vivo neurogenesis requires a stable labeling technique for
dividing cells and their progeny. BrdU is incorporated in dividing cells; however, under
some circumstances and certain concentrations it can also label cells undergoing DNA
synthesis, including DNA repair. Nevertheless, several experimental data argue against
the concern that the concentration in which BrdU is commonly used may be sufficient to
detect cells that undergo DNA repair. (1) Mitotic figures and cell cycle markers can be
detected in regions of neural progenitor cell activity.  (2) Over time, BrdU positive cells
undergo development from dividing precursor cells to fully mature neurons, as
demonstrated by immunofluorescence (Figure 9) and electron microscopy. (3) Studies
using retroviral vectors, which integrate exclusively into dividing cells, confirmed the
thymidine labeling studies of adult progenitor cell proliferation and neurogenesis. (4)
Apoptotic cell death, which is accompanied by activation of DNA repair mechanisms, is
not labeled by BrdU incorporation. (5) Irradiation drastically and immediately reduces the
number of BrdU labeled cells in vivo, although DNA repair is increased after irradiation.
Taken together, these findings confirm that neurogenesis is not an artifact, but a
prominent characteristic of the adult mammalian brain. Nevertheless, observation of
neurogenesis in new species or new brain regions, as well as in disease models,
requires careful histological analysis in order to avoid false-positive results.
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Experiment II - Impaired adult neurogenesis in mice
lacking the transcription factor E2F1
(Cooper-Kuhn et al., 2002, Molecular and Cellular Neuroscience 21:312-323)
Objective
During nervous system development the fate of neural progenitors - whether to
undergo proliferation, differentiation or apoptosis - is controlled by various signals, such
as growth factors.  This experiment addressed the question of whether the transcription
factor E2F1, which is targeted by several signaling cascades that are activated by
growth factors, is involved in neurogenesis in the adult brain.  Using a knockout strategy,
the adult brains of E2F1-/- mice were analyzed, focusing on regions of adult neural
progenitor cell proliferation, neurogenesis and cell death.  Five separate analyses to
address the effect of E2F1 deficiency on postnatal neurogenesis were performed: (1)
Brain and body weights of E2F1-deficient and wildtype mice as neonates and as adults
were compared to get an overall measure of alterations that may occur during postnatal
maturation of the brain. (2) A neuroanatomical characterization of adult E2F1-deficient
brains gives indications whether developmental brain defects are present that would
compromise the analysis of adult neurogenesis. This analysis includes the stereological
neuronal counts in the cerebellum, a brain structure predominantly generated
postnatally, in comparison to the neocortex, whose neurons are generated entirely
during embryonic stages. (3) To study the effect of E2F1-deficiency on adult neural
progenitor cell proliferation in vivo, BrdU labeling and stereological analysis was
employed to determine the number of cells in S-phase in the hippocampus and in the
LV. (4) Consecutively, in the hippocampus and OB, the number of new neurons being
generated from dividing progenitor cells 4 weeks after BrdU labeling was determined. (5)
Finally, because E2F1 has been reported to be involved in cell death of postmitotic cells,
the frequency of apoptotic cells in the regions of adult neurogenesis was also
determined.
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Introduction to Experiment
The E2F family of transcription factors has been implicated in controlling
proliferation as well as cell death of embryonic cells, including neural progenitor cells in
vitro179. Therefore, it was hypothesized that individual E2F family members may play an
important role during generation and replacement of neurons in the adult brain. The E2F
transcription factors consist of a family of 7 genes (Figure 12), and these transcription
factors regulate the expression of genes whose products are important in cell
proliferation, from the G1 to the S phase of mitosis.  A functional E2F transcription factor
consists of an E2F peptide heterodimerized with a DP1 or DP2 peptide.  E2F-1, -2, and
–3 are the closest related family members, all sharing the capacity to efficiently induce
the S phase.  E2F-4 and –5, in contrast, are weak inducers.  Their activity is regulated
through their association with so called "pocket proteins" (Rb, p107, and p130).  The
retinoblastoma gene (Rb) can inhibit the transcriptional activation capacity of E2F
factors by masking their transcriptional activation domain – this converts them to
transcriptional repressors180-182.  During G1 phase, D-type cyclins modulate Rb by
activating cyclin-dependent kinases, which in turn phosphorylate Rb.  Once Rb is
hyperphosphorylated (late G1), it releases transcriptionally active E2F factors (Figure
13).
Figure 12
E2F family members and their dimer peptides (DP1/2).
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Figure 13
Depiction of cell cycle.  During G1 phase, Rb becomes phosphorylated by cyclin kinases.  Once Rb is
hyperphosphorylated, its conformation changes, thus releasing active E2F, which is thereby able to
regulate the expression of a number of genes whose products are required for S-phase entry. Free E2F is
deactivated by Cyclin-A/Cdk2 during S-phase. Multiple mitogenic signaling pathways, as well as growth
inhibitory signals, ultimately converge upon E2F at the G1 phase checkpoint (with permission from M.
Vroemen).
Within most cell types, the overexpression of E2F1 serves to induce
proliferation183-185; however, it is also capable of inducing apoptosis in ceratin cell types,
probably through a protective, apoptotic pathway that eliminates cells that have lost their
cell cycle control186. In E2F1-deficient mice, organs like the testis suffer from atrophy,
whereas a reduced apoptotic elimination of thymocytes during T-cell maturation leads to
a postnatal hyperplasia of the thymus185, 187. Moreover, E2F1-deficient mice have a
higher risk of developing intestinal tumors in later stages of life185, leaving it open as to
whether organs such as the brain are affected in one way or another.
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Of the six E2F family members, E2F1 is most prominently expressed in the
embryonic nervous system, with high abundance in regions of neural progenitor cell
activity188-191. Nevertheless, mice with targeted deletion of E2F1 appeared normal in
gross anatomy and behavior compared to wild type mice, probably due to functional
compensation by other E2F family members185, 187. E2F1 continues to be expressed in
the nervous system in postnatal periods while other E2F family members are
downregulated at later stages of development188-191. Therefore, it was hypothesized that
a possible effect of E2F1 deletion in the CNS could reveal a phenotype in postnatally
and/or adult generated granule cell populations of the OB, hippocampus and
cerebellum.
Experimental Design
For specific details on Experimental Design, see Materials and Methods on page 106.
RESULTS
Loss of E2F1 affects size of adult mice and brain weight.
As a basic, but crude measurement for quantitative changes in E2F1-deficient
mice, the body weight and the wet brain weight of wildtype and E2F1-deficient animals
at 4 days after birth (neonatal) and at 3 months of age (adult) was first compared. Table
1 shows that neither body weight nor brain weight differed between newborn wildtype
and E2F1-deficient mice. However, in adulthood, the E2F1-deficient mice were slightly,
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but significantly, smaller in body weight (20% reduction) and brain weight (10%
reduction) compared to wildtype, which is in accordance with previous data on atrophy
of several organs185, 187.
Table 1
Neonatal and Adult Body and Brain Weights
Wildtype E2F1 deficient P value
Neonatal (P4)
Body weight
Brain weight
2.384 + 0.054
0.196 + 0.004
2.504 + 0.125
0.206 + 0.006
0.39
0.16
Adult (P90)
Body weight
Brain weight
27.591 + 1.087
0.475 + 0.007
22.083 + 0.941
0.431 + 0.005
0.001**
0.001**
Neonatal and adult body and brain weights were determined on postnatal day 4 (P4) and day 90 (P90),
respectively (n = 12 per group). Equal numbers of male and female mice were used. Weights (g) are
presented as group means +/- SEM. Significance levels in the unpaired two-tailed t-test are given as P
values.** Statistically significant difference between wildtype and E2F1-deficient mice at the 1% level.
Neuroanatomy of adult E2F1-deficient animals
The study of neural progenitor cell activity in adult mice with targeted mutations
requires that the animals are viable and have no apparent abnormalities from embryonic
brain development. E2F1-deficient mice have been reported to be fertile, viable, and
without gross anatomical malformations185, 187. Since the brains of E2F1 deficient
animals have not yet been systematically analyzed, the brain morphology of E2F1
deficient animals was compared with wildtype littermates. Analysis of multiple brain
regions, such as neocortex, diencephalon, midbrain and cerebellum, on Nissl-stained
sections revealed no missing or overtly altered cell groups (Figure 14A). All layers of the
neocortex are present and appear to have identical organization and size (Figure 14C).
To detect possible differences between prenatally and postnatally generated brain
structures, neuronal cell numbers in the neocortex, whose neurons are generated
exclusively during the embryonic phase, were compared with the postnatally generated
GCL of the cerebellum. Stereological cell counts of Nissl-stained tissue sections
revealed a small, but significant reduction in the number of cerebellar granule cells in
E2F1-deficient mice (Figure 14B). In contrast, the neuronal numbers of the neocortex
were not significantly decreased (Figure 14D). These data implicate that structural
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changes, due to the lack of functional E2F1 protein, become more prominent in
postnatal stages of life.
Figure 14
Neuroanatomical characterization of E2F1-deficient animals. (A, C) Anatomical overview of adult E2F1-
deficient brains in comparison to wildtype as demonstrated on representative Nissl-stained parasagittal
sections. The E2F1-/- brains appear to develop normally. The presence of multiple brain nuclei in the
forebrain, thalamus, hypothalamus, ventral midbrain, and brain stem (details not shown) as well as the
normal layering of the neocortex (C, primary motor cortex) were confirmed. (B, D) When neurons in the
cerebellum and the neocortex were counted, a significant reduction in cerebellar granule cell numbers (B)
of E2F1-deficient mice was observed, whereas cortical neuron numbers (D) were not altered. Neuronal
cell counts are represented as group means +/- SEM (n=6 animals per group). *Statistically significant
difference between wildtype (WT) and E2F1-deficient mice at the 5% level (Student’s t test).
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Loss of E2F1 leads to less proliferation in dentate gyrus and subventricular zone.
In order to determine the role of E2F1 in adult neurogenesis, neural progenitor cell
proliferation in the DG and the LV wall was analyzed. Adult E2F1-deficient and wildtype
littermates (2 months of age) received a single BrdU injection (50 mg/kg) 2 hrs before
perfusion (n=5 animals per group) to restrict labeling to cells in the S–phase of the cell
cycle.  In the DG GCL, quantification of BrdU-labeled cells detected a significant lower
level of cell proliferation in the absence of functional E2F1 (Figure 15). In the LV a
similar reduction of cells in S-phase was observed (Figure 16).
Figure 15
Proliferation in dentate gyrus visualized by BrdU labeling. (A–C) Cell division in the dentate gyrus granule
cell layer of (A) wild-type and (B) E2F1-deficient mice. Note the typical location of newborn cells at the
inner border of the granule cell layer. (C) Quantification. The dorsal hippocampus was analyzed on
approx. 8 coronal sections per animal (n = 5 per group). The proliferative activity in the dentate gyrus is
expressed as the total number of BrdU-positive cells per dentate gyrus granule cell layer. (D–F)
**Statistically significant difference between wild type and E2F1-deficient mice at the 1% level, (Student’s t
test). Interference contrast optics. Scale bar in A is 100 µm.
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Figure 16
Proliferation in SVZ visualized by BrdU labeling.  Cell division in the subventricular zone of (A) wild-type
and (B) E2F1-deficient mice. (C) Stereological BrdU cell counts are represented as the total number of
BrdU-positive cells per subventricular zone (n = 5 animals per group). *Statistically significant difference
between wild type and E2F1-deficient mice at the 5% (Student’s t test). Interference contrast optics. Scale
bar in D is 50 µm.
Lower numbers of proliferating cells, as observed in the E2F1-deficient animals,
could be due to (i) a lower proliferation rate of the existing neural precursor cells or (ii)
size differences of the proliferative region, which may have restricted the amount of
progenitors during development.  These hypotheses were tested by determining the
density of BrdU-positive cells in relation to the volume (volumetric density) and to the
total number of cells (labeling index). In the DG GCL, 175 BrdU-positive cells/mm3
represent 0.21% of the total cell population in wildtype animals, whereas, in E2F1-
deficient mice, 109 BrdU-positive cells/mm3 represent 0.13% of the total cell population
(p<0.01). A significant difference is also observed in the SVZ with 330,000 BrdU-positive
cells/mm3 representing 34% of the total cell population in wildtype animals, whereas
181,000 BrdU-positive cells/mm3 represent 16% of the total cell population in E2F1-
deficient mice (p<0.05). These results illustrate that the reduced proliferation observed
under E2F1 deficiency is independent from the volume and cell numbers of the
respective proliferative areas.
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Loss of E2F1 results in significant decrease of neurons in dentate gyrus and
olfactory bulb.
In order to determine whether E2F1-dependent changes in proliferation affect adult
neurogenesis, adult E2F1-deficient and wildtype mice were assessed 4 weeks after
BrdU injections (Table 2). The numbers of newborn neurons as presented in Figure 17
were then calculated from the stereological count of BrdU-positive cells and multiplied
with the percentage of neurons among the newborn cells as determined by confocal
microscopy.
Table 2
BrdU Labeling in the Dentate Gyrus, Olfactory Bulb, and Lateral Ventricle Wall
Area Wildtype E2F1 deficient P value
Estimated total number of BrdU-positive cells per structure
Dentate gyrus—4 weeks after BrdU
Granule cell layer
Molecular layer
Hilus
480.7 + 52.7
60.7 + 13.9
23.2 + 5.6
242.6 + 36.3
73.7 + 8.9
25.7 + 6.4
0.003**
0.45
0.77
Olfactory bulb—4 weeks after BrdU
Granule cell layer
Plexiform layer
38,971.9+1609.2
1,972.9 + 187.8
25,718.9 + 1840.0
1,460.2 + 197.2
<0.001**
0.08
Percentage neuronal (NeuN_) cells among newborn (BrdU_) cells
Dentate gyrus—granule cell layer
Olfactory bulb—granule cell layer
73.0%
97.0%
78.0%
93.2%
The number of BrdU-positive cells for each area was estimated using immunohistochemistry and a
systematic randomized sampling procedure (Williams and Rakic, 1988) similar to the optical disector
(Gundersen et al., 1988). Note the high numbers of cells being labeled by a single injection of BrdU.
When combined with confocal analysis these numbers reveal a very prominent neurogenic activity in
the adult mouse forebrain. Values are presented as group means +/- SEM. Significance levels in the
unpaired two-tailed t test are given as P values. ** Statistically significant difference between wild type
and E2F1-deficient mice at the 1% level.
In all brain regions with prominent adult neurogenesis - the GCLs of the DG and of
the OB - a statistically significant reduction of BrdU-positive cells in E2F1-deficient mice
at 4 weeks after BrdU labeling was found (Table 2). When ascertaining the relative
proportion of neurons among the newborn cells, significantly less new neurons were
generated in the adult CNS of E2F1-deficient mice. The number of newborn granule
cells in E2F1-deficient mice was reduced to 53% of control levels in the DG and to about
63% in the OB (Figure 17). Although proliferation of other cell types, such as glial cells
and endothelial cells, were not directly assessed, neighboring regions containing no
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known neurogenesis, but rather glial and endothelial proliferation, e.g. the DG molecular
layer, the hilus region and the olfactory plexiform region, revealed no significant changes
in the number of BrdU-positive cells (Table 2).
Figure 17
Adult neurogenesis in E2F1-deficient and wild-type animals. Decreased numbers of newly generated
granule cells in the dentate gyrus (A–C), the olfactory bulb granule cell layer (D–F), and the olfactory bulb
glomerular layer (G-I) of adult E2F1-deficient mice (n = 7) and wild-type littermates (n = 8). Confocal
analysis was used to determine the percentage of neurons (NeuN-positive cells—red) among the
population of newborn cells (BrdU-positive cells—green) at 4 weeks after BrdU labeling (double-labeling
appears yellow). The total number of newly generated neurons was estimated by combining the
stereologically assessed number of BrdU-positive cells with the percentage of neurons among the BrdU-
positive cells (for details see Experimental Methods) and represented as group means +/- SEM.
**Statistically significant difference between wild-type and E2F1-deficient mice at the 1% level (Student’s t
test). Scale bar in A, 20 µm.
Loss of E2F1 results in decreased cell death in dentate gyrus and olfactory bulb
granule cell layers.
As previously shown for the rat, regions of neurogenesis in the adult mouse CNS
harbor a high density of TUNEL-positive cells; therefore, TUNEL profiles were
quantitatively evaluated in order to detect possible differences between E2F1-deficient
and wildtype mice.  Specificity of TUNEL labeling was controlled by the co-labeling of
52
apoptotic profiles with anti-active caspase-3 antibody (Figure 18).  In E2F1-deficient
animals the numbers of TUNEL-positive profiles in the GCL of the DG and OB were
about 60-70% lower than in wildtype animals (Figure 19A and B). The LV wall revealed
no significant changes in cell death (Figure 19C); however, a trend towards reduced
apoptotic cells was detected.
Figure 18
In order to detect apoptotic cells in tissue sections the TUNEL assay was performed (green
signal in A, B, and D). Other hallmarks of apoptosis, like anti-active caspase-3
immunoreactivity (blue signal in A and C) or nuclear fragmentation (D) colabeled with TUNEL-
positive cells, verify the specificity of TUNEL labeling. Red signal in A and D, anti-NeuN. Scale
bar, 15 µm.
Figure 19
Apoptotic cells were consistently detected throughout the neurogenic regions of the adult brain. (A, C, E,
G) Numerous TUNEL-positive cells (green) were identified in (A) the DG-GCL, (C) the SVZ, (E) the OB-
GCL, and (G) the OB-PGL. (B, D, F, H) Quantification of TUNEL-positive cells in wildtype (n = 8) and
E2F1-deficient mice (n = 7) revealed a significant reduction in the DG-GCL and OB-GCL in the knockout
animals, whereas in the SVZ and OB-PGL no significant changes were detected (Student’s t test). Red
signal, nuclear counterstaining ToPro 3. Scale bars in A, C, E, and G 7.5 µm.
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DISCUSSION
Functional significance of E2F1 in other animal models
Although E2F1-deficient mice are viable and fertile, the functional importance of
E2F transcription factors for cell cycle progression becomes obvious in other animal
models. In drosophila, mutation of the E2F1 homologue (dE2F) is early embryonic
lethal192. Once the maternal contribution of gene products in the fly embryo has ended, a
cessation of DNA synthesis is observed in virtually all cells of the embryo. In mammals,
the functional redundancy of E2F family members becomes apparent when the effects
of multiple deletions are studied. A recent report of fibroblasts defective in E2F1, E2F2
and E2F3 shows a complete abolition of S-phase entry, whereas single and double-
mutant cells were not affected193. From these experiments it becomes apparent that the
E2F transcription factors play an essential role in cell cycle progression, proliferation and
development.
Cell death in regions of adult neurogenesis
Several members of the E2F family of transcription factors affect cell cycle
progression, but E2F1 is the only known member to induce cell death as well181, 186, 187,
194. The mechanism of the pro-apoptotic E2F1 activity is not fully understood, but it is
assumed that forcing proliferation-incompetent cells past the G1-S restriction point of the
cell cycle may induce aberrant proliferation and subsequent apoptosis195-197. In the initial
description of E2F1-deficient mice, one of the most prominent effects found was a
hyperplasia of the thymus due to a defect in apoptotic elimination of thymocytes during
T-cell maturation187. Other experiments demonstrated that overexpression of E2F1 in
postmitotic neurons in vitro induces apoptosis198, 199, whereas elimination of E2F1
function can prevent induction of apoptosis in neurons198, 200, 201.
The effect of E2F1 deficiency on apoptosis suggests that the reduction in
neurogenesis and cell numbers would be more drastic if apoptosis was not affected in
parallel. As for the cerebellar granule cells, it can only be speculated as to how the
neonatal generation of cerebellar granule cells in vivo is influenced by E2F1 deficiency,
since only the total number of cerebellar neurons in adult animals is measured is this
experiment (see Figure 14 on page 47). Compared to the regions of adult neurogenesis
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the reduction in the number of cerebellar granule cells is rather small, perhaps due to an
even stronger decrease in apoptotic elimination of granule cell progenitors. Along these
lines, in vitro experiments have shown that E2F1 deficiency completely abolishes
neuronal death in cerebellar granule cells induced by beta-amyloid202.
In vitro overexpression of E2F1 leads to a strong upregulation of cell death
activators203. The induction of E2F1 in postmitotic neurons activates DNA-synthesis and
concomitant cell death198, 199. For the pathophysiology of Alzheimer’s disease, it has
become increasingly evident that neuronal cell death is accompanied by an upregulation
of cell cycle activators, including E2F, and S-phase entry204-207. Under E2F1-deficiency,
neurons were resistant to staurosporine-, large T-antigen and low K+-induced
neurotoxicity in vitro198-201. The ability of Myc to induce apoptosis in fibroblasts is also
markedly reduced in cells deleted for E2F1208. These studies hint towards an active and
direct role of E2F1 in the molecular regulation of apoptosis.
Postnatal phenotype of E2F1-deficiency
It has been hypothesized that a functional compensation for the lack of E2F1 is
accomplished by other family members, leading to the assumption that no apparent
phenotype is observed during embryonic brain development of E2F1-deficient mice187.
In fact, five E2F family members are highly expressed in the developing brain and in-situ
hybridization signals for E2F1, E2F2 and E2F5 are preferentially detected in the
ventricular zone, where neural progenitors cells undergo rapid cell division189, 190.
In E2F1-deficient animals the neurogenesis of granule cells in the OB, DG and
cerebellum are affected; however, the number of neurons of the neocortex, which
develops exclusively during the embryonic phase, is unchanged by E2F1 deficiency,
probably due to compensation by other E2F family members188-191. But why are the
other E2F family members downregulated postnatally? One explanation could lie in the
decreased complexity of neurogenic activity in the postnatal brain compared to prenatal
neural development. Postnatal and adult neurogenesis is mainly required for the
production of large homogenous populations of interneurons. Therefore, from an
evolutionary point of view a decline of redundancy between E2F family members in the
postnatal CNS is probably more permissive than during embryonic brain development.
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Adult neurogenesis is a cellular mechanism that encompasses rapid cell division of
neural progenitors cells in the LV and hippocampus, followed by migration and neuronal
and glial differentiation. With a cell cycle length of 14 hrs for progenitors in the LV209 and
25 hrs for the DG25 and the daily generation of several ten thousand neurons in adult
rodent brain, a tight molecular regulation of cell cycle progression and cell death is
required. The present study shows that E2F1 plays a significant role in the generation of
granule cells in the postnatal and adult CNS by affecting proliferation and cell death.
E2F1 deficiency reduces neuronal cell numbers, rather than distorts brain structures,
suggesting a role in controlling the number of granule cells in the postnatal brain.
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Experiments III & IV - Neurotransmitters and their position in
the game of Adult Neurogenesis
Recently, several secreted molecules have been implied in the extrinsic regulation
of cell proliferation within the developing telencephalon (for review see210).  Among
them, neurotransmitters are prominent candidates for transcellular signals that could
influence the development of CNS cells, since they contribute to the extracellular milieu
throughout the CNS maturation period211-213.  Moreover, several studies strongly indicate
the role of neurotransmitters as growth regulators for immature neurons210, 214-221.  Of the
neurotransmitters, the most is known about GABA and glutamate with regard to their
influences on neural progenitor cells.  It has been established that GABA exerts a
variety of trophic influences through the stimulation of the GABAA receptor during neural
development (for review see218, 222) and particularly, GABAA receptor activation can
control the cell cycle kinetics in neuronal progenitors217, 219. Moreover, GABA can
influence other essential aspects of neuronal maturation in vitro and in vivo, such as
neuronal survival, growth cone pathfinding, and neuroblasts movement, including
migration on radial glia223-229.  In the case of glutamate, work has shown that glutamate,
via the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate (AMPA/KA)
receptor activation, could downregulate periventricular progenitor proliferation in rat
embryonic cortical explants219.  In the adult, several studies have shown that glutamate
acts to block DG cell proliferation, although the exact mechanisms by which this occurs
are currently unknown (for review see210).
Other neurotransmitters, such as serotonin, have also been shown to play an
important role during development and progenitor proliferation.  The early occurrence of
serotonergic innervation in developing cortical pathways230, 231 suggests a role for
serotonin in brain circuit formation (for review see232) and synaptogenesis233, 234.
Moreover, 5-HT (serotonin) is required for normal early brain maturation, since the
depletion of 5-HT during this critical period leads to a decrease in synaptic density and
impairs the cognitive capabilities in adult rats234.
Two neurotransmitter systems were chosen in this study – acetylcholine, and
noradrenaline - mainly because of their specific innervations into the DG and the OB.
Although neurotransmitter systems are often studied pharmacologically by the use of
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receptor agonists and antagonists, the current study used neurochemical lesions to
study the effects on neurogenesis for two reasons. First, lesions chronically deplete a
neurotransmitter system and therefore long term effects can be studied. Second,
selective loss of specific classes of neurons is a hallmark of neuropsychiatric diseases,
such as Alzheimer’s disease. Here, the loss of cognitive function appears to be directly
coupled to the loss of cholinergic neurons in the basal forebrain and it is therefore
important to find out which long term consequences the loss of neurotransmitter has
with regard to adult neurogenesis.
Prior to 1999 little was known about the possible effects that acetylcholine and
noradrenaline could have on progenitor proliferation and neurogenesis in the adult
brain.  The next two experiments attempt to address the question as to whether these
three neurotransmitters are able to regulate adult neurogenesis.  In principle there are
two strategies to study effects of neurotransmitter. Most often the pharmacological
approach of stimulating and blocking neurotransmitter receptors is used, however since
there is little knowledge about the receptor subtypes that are present in regions of
neurogenesis, it was decided to use the neurochemical lesion strategy. Here, alteration
in neurotransmitter concentration causes neurotoxin-induced cell death of neurons with
specific neurotransmitter phenotypes and specific innervation into the hippocampus and
the OB.
Experiment III – Cholinergic Denervation Lesion
Objective
This experiment aims at defining the role of cholinergic input into the neurogenic
regions by using an immunotoxic lesion approach.  The strategy is to selectively lesion
the cholinergic neurons of the cholinergic basal forebrain (CBF), which project to the DG
and the OB. The immunotoxin 192IgG-saporin was infused into the LV of adult rats,
leading to specific neuronal cell death of cholinergic neurons of the basal forebrain.  The
specific goals of this experiment were to (1) determine the effects of cholinergic
denervation on hippocampal and OB neurogenesis and (2) to analyze cell death in
regions of neurogenesis after cholinergic lesions to those areas.
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Introduction to Experiment
The cholinergic neurons of the forebrain (CBF), consisting of the medial septum,
nuclei of the vertical and horizontal limbs of the diagonal band, and the nucleus basalis
of Meynert (in human), have a widespread connection to the neocortex, the
hippocampus, the OBs and the amygdala (Figure 20) and are involved in enhancing
cortical responses to incoming sensory stimuli.
Figure 20
Sagittal section of an adult rat brain depicting the different cholinergic innervations.  Of particular
importance to this study is the basal cholinergic forebrain (CBF – red and light blue), which provides
cholinergic innervation to the neocortex, hippocampus, olfactory bulb and amgdala.  The CBF consists of
the medial septum (MS), the vertical and horizontal limbs of the diagonal band of Broca (DB), the nucleus
basalis of Meynert (NBM) and the substantia nigra (SN).  The hippocampus receives its innervation from
the MS and the vertical limb of the DB, whereas the OB receives its innervation from the horizontal limb of
the DB. (Adapted from 235)
Cholinergic innervation into the OB has been shown to be quite extensive, with the
highest amounts of cholinergic fibers present in the glomerular layer and deep external
plexiform layer236-239.  The main olfactory innervation of cholinergic fibers originate from
the magnocellular basal forebrain nuclei - the substantia innominata and the horizontal
limb of the diagonal band of Broca240, 241 - and terminate in the PGL as well as onto the
granule spines (for review see14)
Within the DG, cholinergic innervation is especially in the inner 1/3 of the molecular
layer directly adjacent to the GCL242, where the cholinergic axons make synaptic contact
with dendritic projections of the granule cells (see Figure 4 on page 14).  The role of the
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basal forebrain cholinergic system in learning and memory has held considerable
interest since the discovery of cholinergic neurodegeneration in the basal forebrain in
Alzheimer’s disease.  The hippocampus is well defined in the context of learning and
spatial memory and the cholinergic system seems to be crucially connected to these
functions.  Lesions to the septo-hippocampus connection have been shown to impair
spatial memory in rats243 and acetylcholine has been shown to be not only necessary for
learning and memory244, but its presence within the neocortex is also sufficient to
ameliorate learning deficits and restore memory following damage to the NBM245.
The immunotoxin, 192IgG-saporin, consists of the monoclonal antibody 192IgG,
which is coupled to saporin; a ribosome-inactivating toxin derived from the plant
Saponaria officinalis (soap wort).  The antibody component of 192-saporin is directed
against rat p75, the low-affinity neurotrophin receptor. When injected intracerebrally,
192IgG-saporin binds to the surface of p75 bearing neurons and is internalized by
endocytosis.  Once in the cytoplasm, the saporin moiety escapes endosomes and
enzymatically inactivates the large ribosomal subunit halting protein synthesis and
leading ultimately to cell death246.  Key to this experimental strategy is that the
cholinergic neurons of the basal forebrain specifically express the neurotrophin receptor
p75 and their development and survival depends on the supply of the nerve growth
factor (NGF). When this immunotoxin is administered ICV, the result is widespread with
a massive depletion of ChAT activity in the CBF projections and a substantial p75NGFr-
immunoreactive neuronal loss247-249, while sparing other neurotransmitter systems and
non-cholinergic CBF neurons250, 251. It has been previously shown that a single injection
of 192IgG-saporin results in a complete and selective loss of ChAT-immunoreactive
neurons in the basal forebrain, long-lasting cortical cholinergic hypoactivity, and deficits
in learning and memory tasks248, 252-258.
Experimental Design
For specific details on Experimental Design, see Materials and Methods on page 107.
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RESULTS
In order to evaluate the effect of cholinergic denervation on adult neurogenesis,
adult Fischer rats were infused into the LV with 192IgG-saporin or PBS. Four weeks
after the final BrdU injection, which is sufficient time for allowing the newborn cells to
differentiate, the animals were perfused and tissues prepared for analysis. The DG of
the hippocampus and the OB were analyzed for the amount of new cells generated. To
characterize cell fate, BrdU labeling was combined with the neuronal marker, NeuN,
which recognizes neuronal cell bodies and nuclei143 and the astroglial marker, S100b,
which labels astrocytic bodies259.
ICV injections of 192IgG-saporin result in selective elimination of cholinergic
neurons in medial septum.
Once the animals were sacrificed and perfused, the medial septum was analyzed in
order to be certain that the lesion was accurate and complete.  ChAT immunoreactivity
demonstrates the extent to which the cholinergic forebrain was lesioned (Figure 21).
Figure 21
Extent of cholinergic denervation in medial septum.  ChAT staining showing complete denervation of
cholinergic neurons residing in medial septum (lesioned animal – left, control animal – right).  Note the
residual positively-stained ChAT neurons in the striatum (blue area) due to lack of p75 expression.
Decrease of Neurogenesis in Dentate Gyrus after Cholinergic Denervation
Four weeks after cholinergic denervation, BrdU-positive cells were counted in the
GCL, the molecular layer and the hilus of the DG.  Quantifications revealed a trend
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towards less newly generated cells in the GCL and hilus of the 192IgG-saporin animals
(Figure 22). But since the BrdU-positive cell population can consists of several different
cell types, triple immunofluorescence and confocal laser scanning microscopy
specifically determined the proportion of neurons among the new cells. The total number
of BrdU-positive cells was multiplied by the percentage of neuronal (BrdU+/NeuN+) and
non-neuronal cells (BrdU+/S100ß+ or BrdU+/NeuN-/S100b-).  In the granule cells layer
of the DG, there was a statistically significant 35% decrease in the number of new
neurons (p<.05).  On average, 1342 new neurons in the GCL of lesioned animals were
detected; whereas, in the control animals 2064 newly born neurons were counted
(Figure 23).
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Figure 22
Bars represent total numbers of BrdU-positive cells within hippocampus of control animals (blue) and
cholinergic lesioned animals (red).  The hippocampus was divided into granule cell layer (A), molecular
layer (B) and hilus (C).  There was a trend towards less newly formed cells within the GCL and hilus;
however, there was a significant increase in proliferation within the molecular layer (B).
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Figure 23
Graphs depicting the total number of newborn neuronal (blue) and non-neuronal (red) cells in the
hippocampus.  In the granule cell layer (A) there was a significant decrease in the number of newborn
neurons after lesion, whereas the number of non-neuronal cells increased.  In the molecular layer (B),
there was a significant increase in the number of non-neuronal cells, whereas in the hilus (C) there was
no significant difference.  Newborn neurons were not observed in the molecular layer or hilus.
Cholinergic Denervation causes increase in Non-neuronal Cells in the Dentate
Gyrus
The granule cells layer consists mainly of neurons but a few non-neuronal cells are
generated as well.  When the non-neuronal BrdU-positive cells in the GCL were
quantified, a 205% increase was detected (p<.05, Figure 23A). Within the DG, the
molecular layer and hilus were also analyzed and served as a control area, since these
regions, under normal circumstances, do not generate new neurons in the adult.  The
molecular layer showed a significant increase in BrdU-labeling (p<.05, Figure 23B),
whereas the hilus shows a tendency towards a decrease (Figure 23C). The molecular
layer and GCL are directly perturbed by the loss of incoming axons, and these regions
have previously been described to contain a high number of proliferating microglia after
denervation260.
Cholinergic Denervation causes an increase in Cell Death in the Dentate Gyrus
Compared to non-neurogenic regions, the DG and the OB contain more than 10-
fold higher numbers of apoptotic cells.  Therefore, the question of whether or not
cholinergic denervation has an effect on cell death in the GCL was addressed.  At a time
point (five weeks after lesion) when the lesion is permanent, but the hippocampus is still
denervated, apoptosis was quantified by TUNEL labeling.  A 77% increase in TUNEL-
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positive cells in the GCL was observed (p<.05) of the lesioned animals (Figure 24).
TUNEL-positive cells were also quantified in the molecular layer and the hilus; but in
contrast to the GCL, these regions had no significant changes in TUNEL labeling.
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Figure 24
Graphs depicting cell death in the hippocampus after cholinergic denervation.  In the granule cell layer
(A) there is a significant increase in TUNEL-positive cells after lesion, whereas in the molecular layer
(B) and hilus (C) there is no change.
Decrease of Neurogenesis in Olfactory Bulb after Cholinergic Denervation
Two neuronal cell types are generated in the adult OB, granule cells and
periglomerular neurons (see on page).  Therefore the analysis of the OB was subdivided
into the granule cell layer (GCL) and the periglomerular layer (PGL) in order to assess
whether these regions are affected differently by cholinergic denervation.  Within the
GCL, five weeks after the lesion, there was a 34% decrease in the number of newborn
neurons (p<.05), along with a 35% decrease in new non-neuronal cells (p<.05) of the
lesioned animals.  A total of 77,265 new neurons were counted in the GCL of the PBS
animals, whereas in the 192IgG-saporin animals, there was a total of 51,344 new
neurons (Figure 25A).
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Figure 25
(A) Cholinergic denervation causes a decrease in the number of newborn neuronal (blue) and non-
neuronal (red) cells within the granule cell layer of the olfactory bulb. (B) Cholinergic denervation
causes an increase in the number of non-neuronal cells (red) within the periglomerular layer of the
olfactory bulb, while leaving the newborn neuronal (blue) population unchanged.
In contrast to the GCL, the number of newborn neurons in the PGL was
unchanged.  However, there was a 100% increase (p<.05) in newborn non-neuronal
cells in the PGL of lesioned animals (Figure 25B).  This increase in non-neuronal cells
may be due to the presence of microglia into this region after denervation, similar to the
reported increase in microglial cells after denervation of the DG260.
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Cholinergic Denervation causes an increase in Cell Death in the Periglomerular
Layer
As previously shown that in the adult rat, the highest number of TUNEL-positive
cells in the brain are found within the OB, primarily within the GCL28.  A 63% increase
was detected in the number of TUNEL-positive cells (p<.05) in the PGL of the lesioned
animals (Figure 26B) but a non-significant trend towards less apoptotic cells in the GCL.
One would expect to see an increase in cell death in the GCL (Figure 26A), particularly
since a significant decrease in the generation of new neurons was observed (Figure
25A); however, TUNEL-positive cells were quantified five weeks post-lesion, which is
late enough after the lesion that one would no longer be quantifying the acute cell loss
due to an acute denervation lesion.
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Figure 26
Cholinergic denervation has no effect on cell death in the granule cell layer of the olfactory bulb
(top); however, cell death is increased within the periglomerular layer after lesion (bottom).
DISCUSSION
Lesion of the CBF system, generated by ICV injections of 192IgG-saporin, leads to
less newly born neurons in regions of adult neurogenesis.  In the hippocampus, a 35%
decrease in the number of newly generated granule neurons was detected. Therefore, it
can be proposed that the cholinergic system plays a stimulatory role for neurogenesis.
However, it cannot be answered with this experiment whether or not acetylcholine acts
directly on the neuronal progenitor cells in the adult brain and would need, for example,
in vitro studies on isolated cells.  In addition, the effects on neurogenesis after lesioning
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the CBF could be due to either primary or secondary effects.  Acetylcholine could act
directly on the progenitor cells within the hippocampus and SVZ, or it could act indirectly
through other neurotransmitters and their systems.  These speculations, nevertheless,
cannot be answered by this experimental approach.
The cholinergic system is known to be involved in information processing related to
learning and memory. In particular, the loss of cholinergic function has been associated
with cognitive decline during aging and in Alzheimer’s disease. Although still correlative,
several arguments support the view that hippocampal neurogenesis might be involved in
similar cognitive functions.  (1) Enriched environment increases neurogenesis and
spatial learning in the Morris water maze, a hippocampus dependent task91.  (2)
Learning situations can increase neurogenesis261, 262.  (3) Hippocampal neurogenesis
decreases with aging19, 263.  (4) Restoring neurogenesis in aged animals ameliorates
symptoms of age-dependent cognitive decline38, 104, 116, 264. Although it is too early to
connect neurogenesis to disease progression in neurological disorders such as
Alzheimer’s disease, it is intriguing to propose that the loss of neuronal elements may
not only be based on cell death of mature neurons but on the decreased production of
new neurons as well.  Based on this theory, neurodegeneration could be redefined in
certain cases as an imbalance in production vs. elimination, rather than the inability to
sustain the survival of a fixed number of neurons. This is still a provocative hypothesis,
however it may open completely new avenues to find novel therapeutic strategies for
neurodegenerative diseases.
Besides reduced neurogenesis in the DG, a similar decrease in neurogenesis was
observed after cholinergic denervation in the GCL of the OB.  Even though the function
of adult olfactory neurogenesis has not yet been determined, it can be assumed from
several studies that neurogenesis is involved in olfactory information processing, such
as olfactory discrimination learning94, 265, 266, 11. In this regard it is also relevant to
mention that cholinergic input to the OB has been shown to be directly involved in local
neuronal plasticity related to olfactory learning267-269. As a clinical perspective, numerous
reports demonstrated the connection between olfactory deficits and neurodegenerative
diseases.  For example, functional testing of Alzheimer’s patients reveals significant
impairment in olfactory function (for reviews, see270-273). Moreover, aged rats have
impairments in olfactory reversal learning274, which could have a possible correlation
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with the fact that neurogenesis decreases with age in the rat OB275.  Taking these
observations together with the current experiment, it is possible that one of the functions
of the cholinergic input into the OB is to regulate the extent of neuronal production. It is
however too early to conclude that neurogenesis is involved in the olfactory pathology of
certain neurodegenerative diseases.
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Experiment IV – Noradrenergic Denervation Lesion
Objective
This experiment aims at defining the role of noradrenergic input into the neurogenic
regions by using a chemical lesion approach.  The strategy is to selectively lesion the
noradrenergic neurons of the locus coeruleus (LC), which project to the dentate gyrus
and the olfactory bulb. The immunotoxin DBH-saporin was infused into the lateral
ventricle of adult rats, leading to specific neuronal cell death of noradrenergic neurons of
the LC.  The specific goals of this experiment were to (1) determine the effects of
noradrenergic denervation on hippocampal and olfactory bulb neurogenesis and (2) to
analyze cell death in regions of neurogenesis after noradrenergic lesions to those areas.
DBH-saporin, which consists of a monoclonal antibody to Dopamine beta-
hydroxylase coupled by a disulfide bond to saporin (a ribosome inactivating protein), has
been shown to be selectively toxic to peripheral noradrenergic sympathetic neurons in
rats after systemic276and ICV injection.  Dopaminergic neurons of the substantia nigra
and ventral tegmental area and serotonergic neurons of the raphe, all monoaminergic
neurons that do not express DBH, survived all anti-DBH-saporin doses277.
Introduction to Experiment
Figure 27
Depiction of noradrenergic innervation in the adult rat brain.  The locus coeruleus (A6 – in blue) projects to
the cortex, cerebellum, hippocampus, olfactory bulb, and a small portion to the spinal cord.  Of particular
interest to this study are the noradrenergic neurons projecting from the LC to the hippocampus and
olfactory bulb. (Adapted from 235)
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The majority of noradrenergic neurons reside in the locus coeruleus of the pons.
These neurons project throughout the cortex, cerebellum and spinal cord (Figure 27).  A
large portion of the adrenergic neurons reside in the medulla and project to the spinal
cord, particularly to the sympathetic preganglionic column, and some terminate in the
hypothalamus, as well as a small portion ending up in the locus coeruleus.  There is also
a group of neurons that reside in the nucleus of the solitary tract.
Most interestingly for this study, projections from the locus coeruleus innervate the
hippocampus specifically along the subgranular zone (between hilus and gcl), the region
of progenitor proliferation and neurogenesis. At least 40% of all LC neurons project to
the olfactory bulb; the innervation is almost 10 times greater than to any part of the
cerebral cortex278. Noradrenergic input into the olfactory bulb innervates the granule cell
layer, mitral layers and plexiform layers; however, little innervation into the glomerular
layer has been reported279. In spite of this innervation pattern, no data from
pharmacological or lesion studies on noradrenaline in relation to adult neurogenesis
have been reported thus far.
In the developing brain, noradrenaline may play a role by modulating synaptic plasticity
during critical periods of circuit formation280, 281. In the olfactory bulb, noradrenaline input
from the locus coeruleus (LC) appears to be necessary for the newborn rat to form a
learned odor preference282.
Experimental Design
For specific details on Experimental Design, see Materials and Methods on page 107.
RESULTS
In order to evaluate the effect of noradrenergic denervation on adult
neurogenesis, adult Fischer rats were infused into the lateral ventricle with DBH-saporin
or PBS. Four wks after the final BrdU injection, which is sufficient time for allowing the
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newborn cells to differentiate, the animals were perfused and tissues prepared for
analysis. The dentate gyrus of the hippocampus and the olfactory bulb were analyzed
for the amount of new cells generated. To characterize cell fate, BrdU labeling was
combined with the neuronal marker NeuN and the astroglial marker S100b.
Decrease of Neurogenesis in Dentate Gyrus after Noradrenergic Denervation
Four weeks after noradrenergic denervation, BrdU-positive cells were counted in
the GCL of the dentate gyrus.  Quantifications revealed a significant reduction in the
number of newly generated cells in the GCL of the DBH-saporin animals compared to
sham-lesioned animals (PBS injection) (Figure 28).  Triple immunofluorescence and
confocal laser scanning microscopy determined the relative amount of neurons vs. other
cell types among the new cells. The total number of BrdU-positive cells was multiplied
by the percentage of neuronal (BrdU+/NeuN+) and non-neuronal cells (BrdU+/S100ß+
or BrdU+/NeuN-/S100b-). Since the percentage of neurons among the new cells did not
differ between DBH-saporin and PBS animals, the production of newly generated
neurons was significantly reduced (Figure 29). On average, 1341 new neurons were
detected in the granule cell layer of lesioned animals, whereas, in the control animals,
2064 newly born neurons were counted.
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Figure 28
Bars represent total numbers of BrdU-positive cells within hippocampus of control animals (blue) and
noradrenergic lesioned animals (red).  The hippocampus was divided into granule cell layer (A),
molecular layer (B) and hilus (C).  Within the GCL, there was a significant decrease in the proliferation of
progenitor cells due to noradrenergic denervation; however, within the molecular layer and hilus, there
were no significant changes.
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Figure 29
Graphs depicting the total number of newborn neuronal (blue) and non-neuronal (red) cells in the
hippocampus.  In the granule cell layer (A) there was a significant decrease in the number of newborn
neurons and non-neuronal cells.  In the molecular layer (B) and the hilus (C) there was no significant
difference.  Newborn neurons were not observed in the molecular layer or hilus.
Noradrenergic Denervation causes decrease in Non-neuronal Cells in the Dentate
Gyrus
The GCL consists mainly of neurons; however, a few non-neuronal cells are
generated as well.  When the non-neuronal BrdU-positive cells in the GCL were
quantified, a 40% decrease was detected (p<.015, Figure 29A). Within the DG, the
molecular layer and hilus were also analyzed and served as a control areas, since these
regions, under normal circumstances, do not generate new neurons in the adult.  The
molecular layer and the hilus show no alteration in the number of BrdU-positive cells
(Figure 29B & C).
Cell Death in the Dentate Gyrus is not altered by Noradrenergic Denervation
Cell death is a prominent regulatory mechanism in neurogenic regions in the adult
brain.  Therefore, the question of whether or not noradrenergic denervation has an effect
on cell death in the GCL was addressed by quantifying TUNEL labeling.  No changes in
the number of TUNEL-positive cells were observed in the GCL of the lesioned animals
(Figure 30). Apoptotic cells were also quantified in the molecular layer and the hilus and
similarly, these regions had no significant changes in TUNEL labeling.
72
A                            Granule Cell Layer
0
10
20
30
40
50
60
70
80
90
PBS, ICV DBH-SAP
A
b
so
lu
te
 #
 T
U
N
E
L
-p
o
si
ti
ve
 c
el
ls
B                            Molecular Layer
0
10
20
30
40
50
60
PBS, ICV DBH-SAP
A
b
so
lu
te
 #
 T
U
N
E
L
-p
o
si
ti
ve
 c
el
ls
C                                    Hilus
0
5
10
15
20
25
30
35
PBS, ICV DBH-SAP
A
b
so
lu
te
 #
 T
U
N
E
L
-p
o
si
ti
ve
 c
el
ls
Figure 30
Graphs depicting cell death in the hippocampus after noradrenergic denervation.  No changes in the
granule cell layer (A), the molecular layer (B) or hilus (C) were observed.
Increased Periglomerular Neurogenesis in Olfactory Bulb after Noradrenergic
Denervation
Two neuronal cell types are generated in the adult olfactory bulb, granule cells and
periglomerular neurons (see Figure 1 on page 11).  Therefore the analysis of the
olfactory bulb was subdivided into the granule cell layer (GCL) and the periglomerular
layer (PGL) in order to assess whether these regions are affected differently by
noradrenergic denervation.  Within the GCL, five weeks after the lesion, there was no
significant alteration in the number of newly generated neurons or new non-neuronal
cells (Figure 31A).
In contrast to the GCL, the number of newborn neurons in the PGL was
significantly increased (108%, p<0.01), whereas the number of non-neuronal cells was
not altered (Figure 31B).
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Figure 31
(A) Noradrenergic denervation causes no alteration in the number of newborn neuronal (blue) or non-
neuronal (red) cells within the granule cell layer of the olfactory bulb. (B) Noradrenergic denervation
causes an increase in the number of neuronal cells (blue) within the periglomerular layer of the olfactory
bulb, while leaving the newborn non-neuronal (red) population unchanged.
Noradrenergic Denervation causes a Decrease in Cell Death in the Olfactory
Granule Cell Layer
As previously shown that in the adult rat, the highest number of TUNEL-positive
cells in the brain are found within the olfactory bulb, primarily within the GCL28.  A 42%
decrease was detected in the number of TUNEL-positive cells (p<.05) in the GCL of the
lesioned animals (Figure 32A), whereas the rate of apoptosis in the PGL was not altered
(Figure 32B).
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Figure 32
Noradrenergic denervation has no effect on cell death in the periglomerular layer of the olfactory
bulb (A); however, cell death is decreased within the granule cell layer after lesion (B).
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DISCUSSION
The major noradrenergic innervation into the dentate gyrus occurs along the border
between the GCL and the hilus, the so-called subgranular zone.  This innervation
pattern corresponds with the reduction in neurogenesis that was observed after
noradrenergic denervation.  Lesion of the noradrenergic neurons residing in the locus
ceruleus with DBH-SAP leads to a 35% decrease in hippocampal neurogenesis.
Therefore, it can be assumed that normal noradrenergic functioning may play a
stimulatory role in hippocampal neurogenesis.  However, as with the cholinergic lesions,
it cannot be determined through this experimental design whether norepinephrine acts
directly on neuronal progenitors or whether the effects are due to indirect pathways.
In addition to the loss of neurons within the dentate gyrus, there was also a
decreased generation of non-neuronal cells, such as astrocytes, within the GCL.  Since
several studies have indicated that the subgranular zone harbors multipotent progenitor
cells, it is possible that the loss of noradrenergic input affects this cell population,
subsequently leading to an overall reduced cytogenesis of neurons and glia.  However,
one cannot rule out the possibility that separate effects of noradrenergic deficiency on
individual lineage-restricted progenitor populations occurred.
In the olfactory bulb, there is a strong noradrenergic projection to the GCL, mitral
layers and plexiform layers from the LC, and this innervation is almost 10 times greater
than in the cerebral cortex278.  However, there were no significant changes in the
number of newly born neurons observed within the OB-GCL.  Conversely, there is very
little innervation into the periglomerular layer279, whereas, lesions to the LC resulted in
an 108% increase in the number of newly born neurons within the PGL.  At this point
there is not enough data to speculate on the reasons for the differential effects of
noradrenergic denervation on olfactory neurogenesis.
A functional role of norepinephrine in neuronal development has been postulated.
For example, norepinephrine is critical in the development of early olfactory preferences
in infant rats283, as well as in reproductive and maternal behaviors284.  Moreover, the
classical view is that released norepinephrine from mature sympathetic neurons and
noradrenergic neurons of the LC is re-uptaken by the norepinephrine transporter (NET).
But NET is also expressed in the young embryo in a wide range of neuronal and non-
neuronal tissues suggesting that NET has additional functions during embryonic
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development (for review see 285) In the locus ceruleus, NET expression is stimulated by
growth factors such as FGF-2, NT-3 and TGF-ß, and subsequently NET regulates
differentiation of noradrenergic neurons in the peripheral nervous system and by
promoting expression of tyrosine hydroxylase (TH) and dopamine beta-hydroxylase
(DBH). In a neuroblastoma cell line, NE induced cell survival, while proliferation was
inhibited286.  Most importantly for this study, desipramine, a tricyclic antidepressant that
blocks norepinephrine reuptake, has recently been reported to induce neurogenesis in
the DG, mainly through a cell survival mechanism that involves activation of cAMP
signaling (for review see 287).  However, similar to the data presented here, the SVZ and
OB system were unaffected.  It is therefore likely that one of the functions of
norepinephrine is specifically regulating the birth of new granular neurons from
progenitor cells in the subgranular zone of the hippocampus.
The reduction of newly born PGL neurons could be due to a chain reaction, since
the mitral cells within the GCL make their dendritic connections with the dendrites of the
PGL neurons. In theory, since the PGL neurons are the first-line connections to the
olfactory nerve layer and are the “first responders” within the OB to olfactory stimulation,
it could be possible that when norepinephrine innervation is missing within the GCL, the
PGL neurons are the ones to suffer, because they may not be able to make their proper
axonal connections.
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Experiment V – Vascular endothelial growth factor induces
neurogenesis in the adult brain
(In submission and in collaboration with Anne Schänzer, Till Acker, Heike Beck, Karl-H. Plate and
H. Georg Kuhn.)
Objective
Previous studies have demonstrated that a multitude of factors, including
hypoxia/ischemia, are strong activators of neurogenesis in the adult mammalian CNS.
Hypoxia, the final condition of several neurological diseases, is a critical stimulus for
neurogenesis, since reduced oxygen levels can promote survival, proliferation and
differentiation of neuronal progenitor cells in vitro288. However, the underlying
mechanisms of neurogenesis and its up-regulation by hypoxia are not fully understood.
Vascular endothelial growth factor (VEGF), a key regulator of developmental, hypoxia-
induced, and tumor-induced angiogenesis, is rapidly up-regulated in response to
hypoxia289-291.  The goals of this experiment were to determine whether VEGF is
involved in the regulation of adult neurogenesis by analyzing neurogenesis in the
hippocampus and OB after infusion of recombinant VEGF into the LV of adult rats.
Introduction to Experiment
It is speculated that apart from its well-characterized effects on the vascular
system, recent studies suggest that VEGF may act directly on neuronal cells. In the
adult brain, VEGF is expressed in neurons and glial cells and under normal conditions,
highest mRNA levels were found in the OB and DG291, the two regions of adult
neurogenesis.  Under hypoxia, cortical neurons and microglial cells express elevated
levels of VEGF, while activation of its receptor Flk-1 (fetal liver kinase-1, otherwise
known as VEGFR-2) is increased on neuronal cells292, 293. VEGF is capable of protecting
cells isolated from the central and peripheral nervous system from apoptosis, as well as
promoting cell survival in vitro294-296. Mice, in which the hypoxia response element has
been deleted from the VEGF promoter, fail to up-regulate VEGF under hypoxia and
develop motor neuron degeneration in the spinal cord297. These data suggest a role for
VEGF as a neurotrophic factor for mature neurons. However, Flk-1 expression has been
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described on progenitor cells from the fetal retinal and cortex298, 299 as well as on
hematopoietic stem cells300, suggesting that VEGF may also be involved in the
regulation of neural progenitors.  The hypothesis was, therefore, that VEGF-signaling
might play a role in the generation of new neurons from neural progenitor cells in the
adult brain.
Studies from our laboratory, in collaboration with Prof. Plate in Frankfurt, have
shown that through the use of a specific antibody against VEGFR-2, a strong and
uniform staining of the ependymal cell layer throughout the LV is revealed. Ependymal
cells lining the lateral and medial side of the LV, demonstrated an intense, cell
membrane-specific staining. In addition, VEGFR-2 expression could be observed in
endothelial cells of medium-sized vessels as well as in neuronal cells, although at lower
levels. Ependymal cells did not express other VEGF receptors, such as VEGFR-1 and
neuropilin-1; however, neuropilin-1 expression was clearly detectable in cells residing in
the SVZ and the RMS.
The choroid plexus plays an important role in supporting neuronal function by
secreting growth factors such as FGF-2, IGF-1, and TGF-ß into the cerebrospinal
fluid301.  High-levels of VEGF mRNA and protein expression were observed in epithelial
cells of the choroid plexus when analyzed by in situ hybridization and
immunohistochemistry. In contrast, little or no VEGF mRNA could be detected in
ependymal cells. Previous reports on VEGF expression in the choroids plexus
suggested a local autocrine function in CSF production by altering the permeability of
the blood-liquor-barrier301; however, using ELISA, VEGF levels in the cerebrospinal fluid
of adult rats suggested an additional paracrine function for the brain. VEGF protein was
also detectable at moderate levels preferentially on the luminal side of the ependymal
layer; however, little or no VEGF mRNA could be observed in ependymal cells,
suggesting that VEGF is not produced by ependymal cells but rather bound to the
receptor. Although other cell types in the CNS, like neurons and astrocytes, are able to
produce VEGF during development or under stress conditions, such as hypoxia, our
data suggest that VEGF secreted into the cerebrospinal fluid by the choroid plexus
epithelium could be one of the primary sources of VEGF for Flk-1 expressing cells in the
LV wall of the intact adult brain.
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Experimental Design
For specific details on Experimental Design, see Materials and Methods on page 107.
RESULTS AND DISCUSSION
VEGF stimulates olfactory neurogenesis.
The presence of Flk-1 in the LV and the production and release of VEGF from the
choroids plexus prompted us to examine whether VEGF infusion in vivo could lead to a
higher number of new neurons generated in the SVZ/OB system.  (For detailed
materials and methods, please see Methods Section).  Immediately after seven days of
growth factor infusion, no significant difference in the number of BrdU-positive cells in
the LV wall could be detected between VEGF-infused (19573 +/- 1987 BrdU-positive
cells, mean +/- standard error) and aCSF-infused animals (25334 +/- 2195, P>0.075, t-
test). This implies that VEGF had little or no influence on the proliferative activity of
neural progenitor cells in the adult LV wall. At 4 weeks post-infusion, however, a highly
significant difference between the two groups was observed. Namely, VEGF-infused
rats had 80% more BrdU-labeled cells in the OB (aCSF: 36249 +/- 3312 vs. VEGF:
58630 +/- 4094, P<0.0005, t-test).
Triple labeling for BrdU, NeuN and S100b , in combination with confocal
microscopy, was performed in order to determine the differentiated phenotype of the
newly generated cells (Figure 33). The relative proportion of neurons among the
newborn cells in the OB did not differ between the groups: 93% of the BrdU-positive
cells were NeuN-positive in aCSF-controls compared to 96% in VEGF-infused rats,
indicating a largely unchanged neuronal differentiation.  On average, 56,000 +/- 3800
new neurons per OB were generated in VEGF treated animals, compared with 34,000
+/- 3080 new neurons in aCSF controls (P<0.0001, t-test) – more than a 60% increase -
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leading to the conclusion that VEGF is a potent stimulator of neurogenesis in the adult
brain.
Figure 33
Increased neurogenesis in the olfactory bulb of (B) adult VEGF-infused animals compared to (A) aCSF-
infused controls. Confocal analysis was used to determine the percentage of neurons (NeuN-positive cells
- red) among the population of BrdU-positive cells (green) 4 weeks after growth factor infusion/BrdU
labeling (double-labeling appears yellow). C, The total number of newly generated neurons was estimated
by combining the stereologically assessed number of BrdU-positive cells with the percentage of neurons
among the BrdU-positive cells and is represented as group means +/- standard error.  (**) indicates
statistically significant differences at the 1% level (t-test). Scale bar in A, 50 µm.
VEGF stimulates hippocampal neurogenesis.
VEGFR-2 has previously been localized within the proliferating clusters of
hippocampal progenitor cells302.  The next step in the experiments was then to
determine a possible effect of VEGF on hippocampal neurogenesis. Immediately after
infusion, proliferation of hippocampal progenitor cells was not affected by VEGF (aCSF:
2235 +/- 266 BrdU-positive cells vs. VEGF: 1944 +/- 185, P>0.38, t-test). However, as
depicted in Figure 34, VEGF-infusion stimulated the generation of approximately 60%
new neurons (aCSF: 1024 +/- 97 BrdU/NeuN-positive cells vs. VEGF: 1687 +/- 129, P<
0.001, t-test). Since similar data in the DG and in the LV/OB system was observed, it
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was concluded that VEGF infusion promotes adult neurogenesis by exerting a survival
effect on neuronal progenitor cells.
Figure 34
Increased neurogenesis in the dentate gyrus of (B) adult VEGF-infused animals compared to (A) aCSF-
infused controls. Confocal analysis was used to determine the percentage of neurons (NeuN-positive cells
- red) among the population of BrdU-positive cells (green) 4 weeks after growth factor infusion/BrdU
labeling (double-labeling appears yellow). C, The total number of newly generated neurons was estimated
by combining the stereologically assessed number of BrdU-positive cells with the percentage of neurons
among the BrdU-positive cells and is represented as group means +/- standard error.  (**) indicates
statistically significant differences at the 1% level (t-test). Scale bar in A, 50 µm.
VEGF decreases cell death in SVZ/OB and hippocampus
Increased neurogenesis in the absence of significant changes in neural progenitor
proliferation under VEGF stimulation suggests that VEGF has a survival-promoting
effect on progenitor cells and immature neurons in the adult brain.  Our group has
previously shown in the adult rat brain that programmed cell death is specifically
localized to the areas of neurogenesis and counterbalances the proliferative activity of
neural progenitor cells in the LV wall9, 28. When apoptotic cell death was analyzed in the
LV wall/OB system of VEGF-treated animals, TUNEL labeling in the LV/OB system of
VEGF-treated animals revealed that cell death was significantly decreased immediately
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after infusion, whereas 4 weeks after VEGF infusion no significant difference was
observed. Within the hippocampal DG, the number of apoptotic cells was also
significantly reduced by VEGF to about 50% of the control level (aCSF: 69.5 +/- 9.9
TUNEL-positive cells vs. VEGF: 35.0 +/- 6.3, P<0.005, t-test). Therefore, the increased
neurogenesis under VEGF is very likely due to decreased apoptotic elimination of
progenitor cells and immature neurons. These data support the hypothesis that
programmed cell death is an important mechanism for the regulation of adult
neurogenesis and that VEGF plays an active role in preventing apoptotic cell death.
VEGF does not stimulate proliferation of glial cells.
Since VEGF is known to stimulate proliferation of other cell types, such as
endothelial cells, the non-neuronal fraction of newborn cells in the OB was evaluated,
however no differences were observed (aCSF: 2396 +/- 188 cells vs. VEGF: 2478 +/-
156, P>0.8, t-test, see also Figure 33C). Similarly, the number of non-neuronal BrdU-
positive cells in the DG GCL were not altered (aCSF: 209 +/- 44 cells vs. VEGF: 182 +/-
34, p>0.6, t-test). Analysis of regions, such as the molecular layer of the DG where
neurogenesis does not occur but rather genesis of endothelial and glial cells, also
revealed no changes in the number of BrdU-positive cells (aCSF: 682 +/- 75 cells vs.
VEGF: 686 +/- 124, P<0.49, t-test), suggesting a specific effect of VEGF on the neuronal
progenitor populations in the adult brain. Thus, VEGF did not induce endothelial cell
proliferation in the brain.
VEGF does not induce neovascularization of the ventricle wall or the dentate
gyrus.
These data demonstrate an effect of VEGF on neurogenesis in the adult brain,
however VEGF is most prominently known for its effects on the vascular system. In
addition, vascular VEGF mediates the testosterone-induced stimulation of neurogenesis
in adult songbirds by release of BDNF (brain-derived neurotrophic factor) from the
vasculature303. In order to verify whether ICV infusion of VEGF into the rat brain exerted
its effect on neurogenesis indirectly through signaling from vascular cells, it was
determined whether endothelial proliferation or vascular permeability were altered. At
the dosage used, VEGF did not induce neovascularization adjacent to the LV or in the
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DG as determined by quantitative immunohistochemistry against the rat endothelial cell
marker, RECA. Moreover, when the dividing non-neuronal cells in the neurogenic
regions were analyzed, which consisted mostly of glial and endothelial cells302, no
differences between VEGF and aCSF-treated animals were observed. Secondly, Evans
blue dye was injected intravenously into a separate set of animals on the last day of
intraventricular VEGF infusion and no leakage in the blood-brain-barrier of VEGF-
treated animals was detected compared to controls. Moreover, a change in brain volume
was not observed, which would imply enhanced vascular permeability. These
observations, together with expression patterns of VEGF and Flk-1 strongly suggest that
VEGF affects neurogenesis rather directly than indirectly via the vascular system.
A close interaction of the vascular system and neurogenic activity in the adult brain
has recently been suggested302, 303, however an indirect effect of VEGF by increasing
vascular permeability was proposed. The fact that VEGF can regulate neurogenesis in
the adult nervous system, and that neural progenitor cells directly respond to VEGF via
activation of the VEGF receptor Flk-1, adds an unexpected novel dimension to
angiogenic/neurogenic interactions. Moreover, the production and release of VEGF from
the choroids plexus indicates a possible new route of controlling neurogenic activity in
the brain.
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Experiment VI – Transient expression of doublecortin during
adult neurogenesis
(Accepted by J. Comp. Neurol. in collaboration with Jason Brown, Sebastien Coulliard-Despres,
Jürgen Winkler, Ludwig Aigner, H. Georg Kuhn.)
Objective
During the development of the CNS, the microtubule binding protein doublecortin
(DCX) is associated with migration of neuroblasts.  Besides this developmental role,
expression of DCX remains high within certain areas of the adult mammalian brain.
These areas, mainly the DG and the LV wall in conjunction with the RMS and OB, also
retain the capacity to generate new neurons into adulthood.  Adult neurogenesis is
typically detected by incorporation of bromodeoxyuridine (BrdU) into dividing cells and
co-labeling of BrdU-positive cells with markers for mature neurons.  In order to elucidate
whether DCX could act as an indicator for adult neurogenesis and possible replace the
use of BrdU, the temporal expression pattern of DCX in neurogenic regions of the adult
brain was investigated. The purpose of this study was 1) to elucidate the spatial-
temporal pattern of DCX expression within the neurogenic regions of the adult rat CNS,
(2) to determine the onset of DCX expression in newly generated precursor cells, (3) to
ascertain the duration of the DCX expression during the neuronal maturation process,
and (4) since a decline in adult hippocampal neurogenesis is known to occur in aged
animals 19, changes in DCX expression with aging was also investigated.
Introduction to Experiment
In order to detect neurogenesis, techniques such as incorporation of thymidine-
analogs or retroviral labeling have been used to track dividing cells and their cell fate
within the CNS. However, these methods have their limitations in the detection of
neurogenesis as described in Experiment I.  The difficulties associated with these
methods call for new, specific and quantifiable indicators of neurogenesis. Expression of
such a marker should ideally be induced in the neuronal progenitor population in order
to detect the new neurons while being generated, and later downregulated in mature
neurons.
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DCX could be such a candidate marker for adult neurogenesis. First detected at
embryonic day 10.5, DCX is expressed at high levels in the developing rat CNS and in
migrating neurons and is required for proper neuronal migration.304-306. Central to this
study, DCX expression is retained within the areas of continuing neurogenesis in the
adult brain307. The morphology of DCX-expressing cells is consistent with that of
migrating neuroblasts. Moreover, many of these cells were co-labeled with PSA-NCAM,
an antigen also present on migrating neuroblasts308. The Dcx gene was originally
described in the context of human migration disorders304, 309, 310.  In addition, mutant
alleles of Dcx provoke a migratory impairment of neural progenitor cells and lead to
lissencephaly or to a subcortical bandheterotopia, or so-called “double cortex
syndrome”304, 309 (for review see311).
Experimental Design
For specific details on Experimental Design, see Materials and Methods on page 108.
RESULTS
Doublecortin expression during adult hippocampal neurogenesis
Time course analysis. The pattern of DCX expression within newly generated
cells was examined by immunofluorescence labeling of DCX and BrdU in the
neurogenic regions of the adult rat brain at different time points after BrdU
85
administration.  At the earliest time point analyzed, i.e. 2 hours post-BrdU administration,
60% of the newborn cells co-labeled for DCX and BrdU (Figure 35 and 36A).
Figure 35
Quantification of BrdU-positive cells expressing DCX, NeuN, or both in the
dentate gyrus.  Note that the peak of BrdU/DCX labeling is around 4-7 days
after BrdU labeling.  BrdU/NeuN double labeling begins to increase after
DCX expression has decreased.  The time of BrdU/DCX/NeuN co-labeling
coincides with DCX expression decreasing and NeuN expression increasing.
The fact that the majority of BrdU-positive cells were expressing DCX at the
earliest time point strongly suggested that proliferating cells were already expressing
DCX. To further substantiate this observation, frequent co-labeling of DCX with Ki67
was also demonstrated in the hippocampus and LV wall (Figure 37). Between the
seventh and tenth day post-labeling, the percentage of BrdU-positive cells expressing
DCX further increased to more than 90% (Figure 36C/D). Thereafter, DCX expression
was rapidly downregulated. It was observed in only 2% of the BrdU-positive cells by one
month and became undetectable by two months after labeling (Figure 36F).
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Figure 36
BrdU time course showing expression pattern of DCX and NeuN in the dentate gyrus.  At 2 hrs after BrdU
labeling, there are clumps of cells that are DCX-positive.  By 7 to 10 days, the BrdU/DCX-positive cells
have spread out along the subgranular layer and the cells begin to take on a different morphology.  By 21
days after BrdU, the majority of the cells are no longer expressing DCX, but rather NeuN (starred cells in
E and F)
Figure 37
Co-labeling of DCX (green) with Ki67 (red) along the subgranular zone of the dentate gyrus (A) and
subventricular zone of the lateral ventricle wall (B).
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Towards the final stage of neuronal differentiation, the newborn cells begin to
express proteins typically present in mature neurons such as the nuclear neuronal
marker NeuN, neuronal-specific enolase (NSE), or calbindin17-19.  For that reason, NeuN
was used to determine when newly generated neuronal precursors become mature and
to what extent their expression overlaps with the expression of DCX. BrdU-labeled cells
immunoreactive for NeuN were first detected in the hippocampus at 10 days after BrdU
injection (Figure 35). The majority of the NeuN positive cells co-expressed DCX
between Day 10 and 14, thereafter NeuN/DCX co-labeling was not detectable anymore.
The percentage of BrdU-positive cells expressing NeuN increased to about 80% one
month after labeling and increased further to more than 90% at later time points
analyzed (Figure 35 and Figure 36F). Adjacent non-neurogenic regions, the hilus and
molecular layers of the DG, were analyzed as control areas. As expected, the co-
localization of BrdU-positive cell bodies with DCX or NeuN was not detected within
these regions (data not shown).
Morphology of DCX expressing cells.  It is interesting to note that the
morphology of DCX-expressing cells changed as neuroblasts matured (Figure 38). Two
types of cellular morphologies were observed. Within the first days after BrdU-labeling,
DCX-positive cells formed a cluster in the subgranular zone adjacent to the inner margin
of the GCL. Some of these cells were without defined processes, whereas others
resembled neuroblasts with processes oriented parallel to GCL (Figure 38A). Later, at
about 10 days after BrdU labeling, DCX-positive cells were integrated into the GCL and
displayed processes spanning the entire layer and further into the molecular layer
(Figure 38B).
Figure 38
Morphology of DCX-positive cells changes over time.  Two hours after BrdU-labeling, DCX co-labeled
cells reside in clumps and assume a horizontal orientation (A).  By 7 days, the cells have a more
neuronal-like morphology, with dendritic processes orientating vertically into the molecular layer (B).
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Doublecortin expression in the aging dentate gyrus.
An age-dependent decrease of neurogenesis within the GCL of the DG has
previously been reported19. Consequently, the analysis of DCX expression was
performed as a function of age. The highest incidence of DCX immunoreactivity was
observed in the younger animals examined, i.e. 2 month old rats. The total amount of
cells expressing DCX notably decreased by 11 months of age, and very few DCX
positive cells were detectable in 21 month old rats (Figure 39). The reduction of DCX-
expressing cells in the DG is consistent with and correlates with the reported age-
dependent decrease in neurogenesis.
Figure 39
DCX expression in the aging dentate gyrus.  The strongest labeling of DCX occurs in the younger animals
(A and B), whereby over time DCX expression decreases and becomes almost non-existent in aged
animals (F).
89
Doublecortin expression in the SVZ/OB system
Subventricular zone/rostral migratory stream.
DCX is already strongly expressed in the SVZ of the LV, where neuronal
commitment already occurs, (Figure 40). Similar to the hippocampus, numerous cells in
the SVZ were double-labeled for DCX and the proliferation marker Ki-67, indicating
frequent cell division of neuroblasts (Figure 37). The morphology of the DCX-expressing
cells in the SVZ is mostly bipolar with short processes (Figure 40A). The DCX-positive
cells are organized in chain-like structures, which has been previously been described
for migratory neuroblasts312. In the RMS, the DCX-expressing neuroblasts have a more
elongated morphology consistent with cells migrating towards the OB (Figure 40B).
Figure 40
DCX expression and morphology in the subventricular zone, rostral migratory stream and olfactory bulb.
In the SVZ, DCX-positive cells (green) have a neuroblasts-like morphology and form chain-like structures
(A).  Once they have moved into the RMS, they assume a more elongated morphology (B) within the
olfactory bulb, they cells adopt a more complex morphology, similar to granular neurons of the OB (C).
Olfactory bulb.
Finally, in the OB the DCX-expressing cells adopt a more complex morphology,
similar to the one observed for the cell integrating into the cell granular layer of the
hippocampus (Figure 40C).  Consequently, BrdU-labeled cells coming from the SVZ
were first detected in the OB four days after BrdU injection. This interval reflects the time
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required for neuroblasts to migrate from the SVZ, where they arise and incorporate
BrdU, to the OB. At four days after labeling, only 2% of the BrdU-labeled cells in the OB
were found to express DCX (Figure 41). At this time point, the percentage is relatively
low since most to the BrdU-labeled cells observed in the OB result from in situ cell
division of non-neuronal cells. As the bulk of newly generated neuroblasts from the SVZ
reach the OB, this percentage increased rapidly. Ten days after labeling, approximately
70% of the BrdU-positive cells in the OB were expressing DCX (Figure 41 and Figure
42D). As in the hippocampus, the BrdU-positive cells expressing DCX within the OB
decreased to undetectable levels by 1 month after labeling and remained undetectable
throughout the subsequent time points (Figure 41 and Figure 42F). The induction of
NeuN expression in newly generated neuroblasts integrating in the OB also appeared to
have a kinetic similar to what is observed in the hippocampus. The co-localization of
BrdU with NeuN was first detected at 14 days after BrdU injection. At this time, 24% of
the BrdU-labeled cells expressed NeuN (Figure 41). The percentage of BrdU-labeled
cells expressing NeuN increased to nearly 90% by 1 month and remained at this level in
the later time points analyzed. Interestingly, in the SVZ/OB system, the co-expression of
NeuN and DCX within neuroblasts was virtually absent.  The reasons for this are still
unclear and need to be definitively answered, but it could be explained by a different
transient expression than in the DG.  It could be possible that the olfactory granule
neurons go through a differentiation phase where they no longer express DCX and
haven’t yet begun to express NeuN.
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Figure 41
Quantification of BrdU-positive cells expressing DCX, NeuN, or both.
Note that the peak of BrdU/DCX labeling is around 10 days.  This
time point is later in the OB than in the dentate gyrus, since the cells
need more time to migrate to the OB granule cell layer.  BrdU/NeuN
double labeling begins to increase after DCX expression has
decreased.  Note that co-labeling of DCX and NeuN is virtually non-
existent.
Figure 42
BrdU time course showing expression pattern of DCX and NeuN in the granule cell layer
of the olfactory bulb.  By 7 to 10 days after BrdU, there are DCX co-labeled cells
detectable (C and D); however, by 21 days and 2 mos, the majority of BrdU-positive cells
have become NeuN-positive as well (E and F).
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Doublecortin expression in the aging olfactory bulb.
As with the hippocampus, OB neurogenesis has been shown to decrease with
age19.  And as with the hippocampus, a decrease in DCX expression in the aging rat
was also observed.  The highest incidence of DCX immunoreactivity was observed in
younger animals, with the total amount of expression notably decreasing by 16 months
of age (Figure 43A-E).  By 21 months, DCX-positive cells were barely detectable (Figure
43F). The reduction of DCX-expressing cells in the OB GCL is consistent with and
substantiates the reported age-dependent neurogenesis decrease.
Figure 43
DCX expression (green) in the olfactory bulb granule cell layer decreases with age.  DCX
immunoreactivity is strong in the young adult rat (A-C); however, with increasing age, expression notably
decreases (D and E) and is barely detected in the aged rat (F).
DISCUSSION
Expression of the nervous system specific protein DCX is associated with neuronal
migration during development of the nervous system and in the adult304-306. DCX is
expressed at very high levels in the prenatal brain and can be detected within most of
the cells in the embryonic intermediate zone, as well as in the cortical plate, but not in
proliferative regions, like the embryonic ventricular zone305, 306. Within these regions,
DCX is expressed by migrating neuronal precursors, both during radial and tangential
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migration305, 306, 310. In the adult mammalian CNS, DCX expression is very low. However,
in some regions including the two neurogenic areas of the adult brain, the SVZ/RMS/OB
axis and the DG of the hippocampal formation, DCX expressing cells are observed299,
307. In addition, DCX expression is up-regulated by conditions that induce or promote
adult neurogenesis and localizes in migrating neuronal precursors141, 304.
Analysis of DCX in newly generated cells showed that DCX is transiently
expressed in proliferating progenitor cells and newly generated neuroblasts.  When the
newly generated cells begin expressing mature neuronal markers, DCX
immunoreactivity is sharply decreased below the level of detection and remained
undetectable thereafter.  The transient expression pattern of DCX in neuronally
committed progenitor cells/neuroblasts indicates that DCX is a suitable marker for adult
neurogenesis and may provide an alternative to BrdU labeling.  This assumption is
further substantiated by our observation that the amount of cells expressing DCX is
decreased with age, which coincides with the previously reported reduction of
neurogenesis in the aging DG.
DCX expression in adult neural precursor cells?
Due to the continuous generation of new neurons in the adult subgranular zone of
the hippocampus and in the SVZ of the LV/RMS/OB axis, active neural progenitor cells
are postulated in these regions. The identity of neural progenitor cells is still under
debate. Detailed electron microscopy studies by Alvarez-Buylla and coworkers,
however, characterized the different cell types in the SVZ, and according to the current
hypothesis, neural progenitor cells of the adult SVZ are slowly dividing cells, most likely
specialized glial cells137, 313 giving rise to fast dividing precursor cells that enter the RMS
and migrate towards the OB.  DCX was found to be expressed in the majority of BrdU
positive cells in the hippocampus 2h after BrdU labeling and was frequently co-labeled
with the proliferation marker, Ki-67, in the hippocampus and SVZ.  It is, therefore, an
intriguing idea that DCX might be expressed in neural progenitor cells. Neither the BrdU
labeling paradigm used in this study, nor the Ki-67 staining can discriminate between the
two possibilities. In some cells of the adult brain, DCX is found to be co-expressed with
nestin, a marker for immature progenitor cells307.  Similarly, DCX co-localizes with
neuronal precursors migrating along radial glial cells in the developing cortex and with
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TuJI-expressing cells in the adult rodent RMS306.  Therefore, the present data support
DCX as a marker for neuronal precursor cells. Interestingly, there is apparently a
difference of DCX expression in proliferative regions of the embryonic and the adult
brain.  DCX is not detected in the embryonic ventricular zone during cortical
development306, but it is expressed in proliferating cells of the adult hippocampus and
SVZ.  This could mean that fetal and adult neural progenitor cells have different
expression patterns and properties.
DCX expression in mature neurons?
DCX is not exclusively expressed in immature neurons, but also found
intermittently in neurons with differentiated morphology within non-neurogenic regions,
including cortex, striatum and corpus callosum307. In addition, DCX labels some
hippocampal mossy fibers into the CA3 region307. In this experiment, DCX expression is
observed in 2% of BrdU labeled cells in the hippocampal DG one month after BrdU
labeling. It is not unlikely, that these cells have already acquired a mature morphology
and grown their axon towards CA3, but still express DCX. The characteristic features of
mature neurons that express DCX are not known. It might be, that these comprise
neurons associated with higher levels of structural plasticity. At least in the cortex and in
hippocampal mossy fibers, structural plasticity and sprouting is a well-documented
phenomenon. Structural plasticity, like axonal sprouting and dendritic rearrangement,
and neuronal precursor cell migration are regulated by the same underlying cellular
mechanisms resulting in re-modeling of the neuronal cytoskeleton. Since DCX is a
microtubule-associated protein that binds, bundles and stabilizes microtubules, DCX
could be integrated into various neuronal cytoskeleton-depending scenarios including
migration of neuronal precursor cells, nuclear translocation, and axonal and dendritic
maturation. LIS1, a protein functional similar to DCX and associated with neuronal
migration, has been shown to regulate neuroblast proliferation, nuclear translocation and
positioning, dendritic elaboration and axonal transport in drosophila314, 315. Similar
activities for DCX, depending on the cellular background in which it is expressed, could
be postulated.
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DCX, a transient marker for neuronal committed precursor cells.
DCX was originally described to be associated specifically with migrating neurons
during development and in the adult; however, the present data support DCX as a
transient marker for neuronal committed precursor cells.  As the number of BrdU-labeled
cells that express DCX starts to decline, labeled cells expressing NeuN can be detected.
One could argue that DCX-expressing cells have a short half-life and that these NeuN-
positive cells originate from a different population of BrdU-labeled cells that required a
period of time to mature. Two aspects, however, argue against this hypothesis. Firstly,
90% of the BrdU-labeled cells in the hippocampus expressed DCX ten days after BrdU
incorporation. Although the number of BrdU-labeled cells diminishes with time, only
about 25% of the BrdU are lost between the tenth days and the first month after BrdU
administration9.  Therefore, the death of some BrdU-labeled cells is clearly insufficient to
explain the loss of DCX-expressing cells with time. Secondly, as the number of DCX-
expressing cells declines, the number of NeuN-expressing cells, in contrast, increases
among the BrdU-labeled cells. During this period of transition, BrdU-positive cells that
co-expressed DCX concomitantly with NeuN were observed. This demonstrated that the
populations of DCX- and NeuN-expressing cells originate from the same precursors, but
are at different stages of neuronal maturation. The low frequency of co-expression of
these two neuronal proteins within the same cell reveals the short period of overlapping
expression.
In the hippocampus, where migration is only a minor event, DCX is expressed in
neuronal precursors for the same amount of time (up to one month) as it is expressed in
neuronal precursors in the SVZ/OB system, where neuronal precursors migrate long
distances.  In the hippocampus, neuronal precursors migrate only a very short distance
from the subgranular zone into the granular layer of the DG.  The more striking event is
a rearrangement of cellular processes, the elaboration of dendritic and axonal
processes, and a general change of cell morphology towards a mature neuron. Similar
events occur during structural plasticity of mature neurons, where synaptic refinement
and collateral sprouting play major roles. The onset of neuronal maturity of neuronal
precursor cells in the SVZ/OB and hippocampus, using NeuN as a marker, is roughly
the same, i.e. about three to four weeks.
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In this experiment, DCX is specifically expressed and only detected in neuroblasts
within the first month after their emergence.  This observation was made in two
independent sites of adult neurogenesis, the hippocampal formation and the SVZ/OB
system. The temporal expression pattern and specificity of DCX within the adult
neurogenic regions therefore suggest that DCX can be a useful marker for
neurogenesis.  Recent studies have begun to employ DCX as a marker for new neurons
in the classical neurogenic regions, but also in the cortex141, striatum316 and the CA
region of the hippocampus317.
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CONCLUDING DISCUSSION
The present dissertation aimed at finding molecular signals that define the
microenvironment of neural progenitor cells and that may regulate neurogenesis in the
adult brain. The focus was on the analysis of three separate classes of molecules:
transcription factors, growth factors, and neurotransmitters and their possible function
during adult neurogenesis. In general it can be concluded that altering the availability of
these factors can modulate neurogenesis.
Transcription factors were chosen, because most extracellular signals, such as
growth factors, neurotrophic factors and cytokines, act through extracellular receptors
which signal to the nucleus to change gene transcription. A key transcription factor for
the control of proliferation is E2F, which is essential in promoting the transition from G1
to the S-phase of the cell cycle. This experiment was able to show that E2F1, the most
prominently expressed E2F family member in the brain, is involved in postnatal and
adult neurogenesis, because E2F1 deficient mice had significantly reduced neuronal
progenitor proliferation. The use of a knockout strategy to analyze adult neurogenesis
was only possible, because other E2F family members apparently compensate for the
lack of E2F1 during embryonic brain development. The involvement of a key
transcription factor for cell cycle control in adult neurogenesis is not a surprise, since all
new neurons are generated from proliferating progenitor cells; however it was important
to find out (i) whether the most prominently expressed E2F family member (E2F1) is
involved and (ii) whether decreased proliferation is automatically followed by reduced
neurogenesis.  This was the case; however, the effect on neurogenesis would have
been even greater had E2F1 deficient animals not displayed a reduced apoptotic
elimination as well, suggesting that downregulation of apoptosis may have played a role
in downplaying the effects of decreased proliferation.
With respect to other cell cycle regulators, it is important to note that p27 is a
signaling molecule that acts upstream from E2F by inhibiting cell cycle progression.  A
recent study, using p27 knockout mice, has shown that these mice have an increased
pool of neural progenitor cells and a higher number of neurons being generated in the
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adult brain318.  Therefore, p27 knockout data on neurogenesis are in agreement with the
E2F data presented here.
Neurotransmitters are some of the most prominent molecules that define the
extracellular milieu of neurons in the brain.  Although their roles for communication
between mature neurons are mainly studied, these molecules are also effective in
controlling cell fate of immature cells (for review see210). The general conclusion of
Experiments III & IV is that neurotransmitters can alter the microenvironment of neural
progenitor cells, whether directly or indirectly, and that these changes lead to significant
alterations in neurogenesis. In principle, the data suggest that acetylcholine and
noradrenaline are stimulatory to adult hippocampal neurogenesis, since neurotoxin
lesions specific to these neurotransmitter systems lead to a reduced number of new
neurons and serotonin is inhibitory, since an increase in neurogenesis is observed after
neurotoxin lesion to this system.
The cholinergic lesion data are the most interesting since elimination of neurons in
the CBF produces not only less neurons but is also known for producing memory
impairment. In addition, neurodegeneration of the cholinergic neurons in the basal
forebrain is one of the hallmarks of the pathology in Alzheimer’s disease patients.
Whether reduced neurogenesis may contribute to the pathology and/or symptoms of
neurodegenerative diseases, such as Alzheimer’s, cannot be determined from these first
correlative evidences, but will need further investigations. It is, however, an intriguing
concept that altered levels of neurogenesis could be directly involved in
neurodegenerative disorders.
Growth factors are, by definition, molecules that stimulate proliferation of certain
cell populations. For that reason, growth factors appear to be an ideal target to stimulate
the proliferative activity of neural progenitor cells. Previous studies from our laboratory,
however, have shown that FGF-2 and EGF, two potent in vitro stimulators of neural
progenitor cell proliferation, have quite different effects in vivo18. Whereas FGF-2
increased neurogenesis in the OB after intraventricular infusion, EGF reduced
neurogenesis and concomitantly increased gliogenesis, probably due to altering the fate
of the multipotent neural progenitor cells. Experiment V involved the testing of VEGF, a
growth factor for a variety of cells, and especially vascular endothelial cells. Again a
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different result was observed than expected: contrary to other growth factors, VEGF did
not increase the proliferation of progenitor cells in vivo, but rather the selective survival
of neuronally-committed progenitor cells, resulting in a strong increase in neurogenesis
in the OB and DG. This trophic effect was confirmed by the fact that apoptotic cell death
was reduced in the neurogenic regions after VEGF treatment.  Therefore, it is possible
to conclude that in this system VEGF functions not as a growth factor in the strict sense,
but rather as a trophic or survival factor. And in this regard, VEGF acts very similar to
BDNF, which also has been shown to induce neurogenesis in the adult rodent brain319-
321.
Neurogenesis: A balance of proliferation and apoptosis
The findings from this dissertation highlight the important fact that adult
neurogenesis depends not only on progenitor proliferation but also on apoptotic
elimination. The number of new neurons being generated at a certain time point
therefore depends not only on the number dividing cells but also on the balance
between cell production and cell elimination.  Adult neurogenesis mimics some of the
processes that occur during embryonic development, where approximately half of the
neurons produced are eliminated in order for the regions of the brain to ultimately
function properly322.  This shows the close relationship between cell birth and cell death
and the intricacies that must be involved.  But, the important point to understand, and
which nature illustrates to us in such elegance, is that this balance exists throughout
development and even further into adulthood and that it works.  In order to
experimentally control neurogenesis, the goal is not to just increase the proliferation of
progenitor cells, because if the balance gets out of control, then an unwanted tumor
could be the possible result. This balance is regulated by a number of factors, genes
and global stimuli, and a large body of recently published work helps to understand the
elements that are responsible (see Table in Appendix).  The experiments described in
this dissertation also show the variability of this system and how genes, growth factors
and neurotransmitters can regulate this balance in very different ways (Table 3).
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Table 3
Method of Intervention Neurogenesis
Cell Death in Neurogenic
Regions
E2F1 knockouts Knockout strategy ‰ ‰
Cholinergic
denervation
Neurochemical Lesion ‰ „
Noradrenergic
denervation
Neurochemical Lesion
‰ (DG)
„ (OB-PGL)
y
VEGF infusion ICV infusion „ ‰
Comparison of the different experimental strategies:
Three different intervention strategies were applied in this dissertation to analyze
adult neurogenesis.  A knockout strategy, such as employed to study the role of E2F1,
enables one to study the influence of endogenous genes and this strategy is an
essential tool for understanding the physiological role of a specific gene.  Nevertheless,
inducible knockouts would probably be a better approach, because the gene’s functions
during the embryonic phase would remain untouched.  In the case of E2F1, it seems
that the other gene family members supplant the loss of E2F1 during development,
since gross anatomical analysis of these animals yielded no malformations.  All the
same, the removal of a gene that is essential to the development of the animal or that
doesn’t have another gene to substitute its function could greatly interfere with the
analysis or understanding of its role in adult neurogenesis.
Neurochemical lesions involve the removal of endogenous neurotransmitters and
help to define the local chemical environment of progenitor cells.  The advantages of
using a neurotoxin (vs. pharmacological agents) are the specificity and selectivity for a
certain cell population.  In the case of 192IgG-saporin, it has been elegantly shown that
this immunotoxin specifically and selectively eliminates p75-immunoreactive neurons in
the cholinergic forebrain and allows one to study the effects of this particular
denervation.  On the other hand, neurotransmitter denervations also cause a multitude
of other side effects, i.e. learning and memory deficits, mood disorders, depression, etc.,
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and one must consider whether or not the effects that one sees on adult neurogenesis
are secondary to the other changes that occur in a lesioned animal.
The utilization of intraventricular infusions enables one to study the effects of
exogenous compounds on adult neurogenesis.  This application has the advantage that
the LV is close to the proliferative region, namely that SVZ and it also eliminates the
problems encountered with the blood-brain barrier.  However, surgery on an animal,
anesthetics and cannula tracts can all have repercussions on progenitor cells and
should be considered when planning these sorts of experiments.  Previous pre-clinical
testing of ICV growth factor infusion has shown that substantial side effects can occur in
proximity to the CSF space, even down to the spinal cord level323.  In addition,
depending on what molecule is being injected, the molecule could have “sticky”
characteristics and not make it farther than the subependymal lining of the LV.  In
Experiment V, since VEGF is endogenously produced in the choroids plexus, it was
unlikely that this growth factor would have these problems.
Disease-related Models and the Clinical Perspective
The adult CNS is classically known as a structure with very limited regenerative
capacity. In this respect the existence of neural progenitor cells in the brain is seen as a
paradox, since multipotent cells in other organs are generally in charge of cellular
replacement after physiological or disease-related degeneration, whereas in the adult
brain spontaneous structural recovery is usually not observed. But some of the
compensatory reactions to injury, which were previously thought to represent synaptic or
functional plasticity, could very well have their origin in a limited neuronal replacement.
Traumatic brain lesion
Traumatic brain injury is capable of causing an increased progenitor population in
the DG324,325  and SVZ325, as well as an increase in the number of newborn neurons in
the DG326.  It is, however, interesting to note that cortical contusions had the opposite
effect – namely, there was a decrease in the number of newborn neurons in the DG327.
Brain injury induced by traumatic lesions can cause a transient increase in the number
of progenitor cells of the LV328-330, but these studies were not able to demonstrate any
neuronal contribution of progenitor cells to the lesion site.
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Epilepsy/Seizure
When epileptic activity is induced in animal models a prominent induction of
neurogenesis is observed in the DG21, 331-335; however, the newborn neurons formed
aberrant connections and did not extend neurites along the mossy fiber pathway to the
CA3 region21. This increase in neurogenesis is observed regardless of the mechanism
for the induction of seizures (e.g. chemical or electrical stimulation). When protective
strategies, such as "environmental enrichment" are employed in combination with
seizure induction, the intervention proved to be effective in preventing seizures and
neuronal cell death93. Nevertheless not all epilepsy-related structural changes are linked
to altered neurogenesis, since progenitor proliferation after seizure was inhibited by
irradiation, whereas the synaptic remodeling of the mossy fiber pathway was not
altered163.  Recently, it has been shown that the neurogenic effects of seizures are not
only affecting the rate of progenitor proliferation in the hippocampus, but also in the LV,
where prolonged seizures up-regulated the rate of SVZ progenitor proliferation336.
Hypoxia/Ischemia
Focal and global ischemia have been shown to be potent in inducing neurogenesis
in the DG of the rat and gerbil and the LV142, 337-341. Ischemic neuronal damage often
involves excitotoxicity, characterized by over stimulation of glutamate receptors and
Ca2+ influx.  This knowledge has led to further exploration of the role of glutamate
receptors in the context of brain ischemia.  It has been observed that of NMDA blockers
systemically injected before and directly following global ischemia completely blocked
the increase in neurogenesis otherwise seen with ischemia121, 339.
The two very promising studies have recently reported that, after ischemia,
neurogenesis is inducible in brain regions which are normally not generated in the adult:
in the striatum and in the CA1 region of the hippocampus. The first study by Lindvall and
colleagues observed after focal ischemia of the striatum that cells from the LV migrate
laterally into the striatum and form new neurons of the type that is most severely
affected, the medium spiny interneurons316. The second study by Nakafuku and
colleagues showed that after global ischemia up to 50% of the damaged CA1 pyramidal
neurons can be replaced317. This regenerative neurogenesis was only observed after a
combination of FGF-2 and EGF was infused into the LV. With an extraordinary broad set
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of methods the study demonstrated that cells divide in the alveus region of the LV,
migrate to the CA1 region, form appropriate synapses and become
electrophysiologicallly active. Moreover, behavioral defects of the ischemia were
compensated only in the EGF/FGF-2 infused animals. Together with data on possible
neurogenesis in the cortex79, 80, 141, these studies demonstrate that the potential for
neurogenesis in other brain areas was previously underestimated.
Taken together, the previous chapters suggest that signals are present throughout
the mammalian brain, which allow limited neuronal self-renewal to occur. Whether this
limited self-renewal contributes to some of the functional plasticity and spontaneous
recovery that can be observed after brain damage, needs to be determined. This
fundamental observation of spontaneous neuronal repair could change our view of the
brain's regenerative capacity; but then again, without giving us the immediate ability to
regenerate large or complex brain areas.
Although the field of adult neurogenesis is not more than 10 years old, a growing
number of factors have been shown to regulate progenitor proliferation and/or
neurogenesis in vivo. The factors most pertinent to the current study were discussed
above; however, it would go beyond the scope of this study to discuss all regulatory
factors.  For a brief summary of which major influences change neurogenesis, see Table
4 below.  For a comprehensive overview of the individual experiments and citations, see
Table I in the Appendix.
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Table 4
Signals/Situations influencing Proliferation and/or
Adult Neurogenesis
Up-regulate Down-regulate
Gonadal steroids Glucocorticoids/Stress
Growth factors Glutamate
Neurotrophic factors Cell cycle inhibitors
Cell cycle activators Aging
Cell death inhibitors Irradiation
Dietary restriction Drugs of abuse (cocain, nicotine,
amphetamine, cannabinoids)
Enriched environment Sensory deprivation
Physical activity Serotonin
Epilepsy Vitamin E
Ischemia and brain injury
Antidepressants
Outlook
During development neural progenitors are generated in germinal matrices, such
as the ventricular zone.  As embryonic and fetal development near the final stages,
these matrices gradually form the SVZ of the LV and the subgranular zone of the DG.
These zones are ultimately the regions that are responsible for the production of new
neurons in the adult brain. Why do they keep proliferating new neurons for these
regions, whereas other areas of the brain grind to a halt?  What makes the cells in these
regions so special?  Is it the environment that’s affording this phenomenon to take
place?  Or could it be a combination of both?  The current experiments have attempted
to contribute answers to these stimulating questions.  Especially in the case of the
neurotransmitter lesions it was possible to show that by altering the input into these
neurogenic regions, thereby changing the microenvironment for these cells, the neural
progenitors responded in varying ways – either by producing more new neurons or less.
Whereas, in a different scenario, changing particular genes and thereby altering the
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program of cell cycle (E2F1 knockout strategy) showed that by specifically altering a
process within the progenitor cell itself results in a decrease in neurogenesis.
In order to make use of this phenomenon of neurogenesis as a possible
therapeutic tool, it will be essential to understand the biological and physiological
significance of new neurons in the adult brain.  Further studies will need to be performed
in order to show that more neurons lead to a better functioning brain.  And once the
stimulus for producing new neurons is understood, then it will be essential to be able to
control the amount of proliferation.  The thought of one day being able to heal
devastating diseases, such as Parkinson’s, Alzheimer’s and even ischemia, provides
hope for a better future.
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MATERIALS AND METHODS
Animals, Injections, and Tissue Preparation
Experiment I - Critical evaluation of BrdU labeling
Female Wistar rats (Harlan, Sulzfeld, Germany) received either a single
intraperitoneal injection of BrdU (50mg/kg) or four consecutive daily injections of BrdU
(50mg/kg/day) at the age of 8 weeks. Animals with a single injection were perfused 2
hours or 2 days later.  During the 2 hr time interval, only cells in S-phase are labeled by
BrdU incorporation.  Animals with multiple BrdU injections were perfused 10 days or 4
weeks later.  The later time interval is sufficient to allow newly generated cells to
undergo full neuronal differentiation.  The animals were perfused transcardially with 4%
PFA/PB. The brains were removed, post-fixed ON in 4% PFA/PB, and transferred to
30% sucrose/PB. The brains were sagitally divided and each hemisphere was cut at
40µm on a sliding microtome in dry ice and stored at -20ºC in CPS.
Experiment II - Impaired adult neurogenesis in mice lacking the transcription
factor E2F1
E2F1 mutant mice were previously generated by inserting a PGK-Neo cassette into
exon 3 and 4187 leading to a deletion of the DNA binding and heterodimer regions. To
reduce the influence of flanking regions from 129/SVJ ES cell construct, the knockout
strain was backcrossed at least 10 times with the C57/BL6 mouse strain. For histological
analysis, E2F1-deficient animals and wildtype C57/BL6 mice were generated as
littermates from heterozygote breedings.
In order to determine the proliferative cell populations in the CNS, 10-12 week old
E2F1-deficient and wildtype mice were injected with BrdU (50mg/kg) and killed 2 hours
later (n=5 for each group). In a second experiment in order to determine the number of
newly generated neurons, animals were treated with a single intraperitoneal injection of
BrdU (50mg/kg) at the age of 8 weeks and perfused 4 weeks later (n=8 for each, E2F1-
deficient and wildtype). The animals were deeply anesthetized with a cocktail of
ketamine, acepromazine and xylazine and perfused transcardially with 4% PFA. The
brains were removed, post-fixed ON in 4% PFA/PB, and transferred to 30% sucrose/PB.
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The brains were sagitally cut at 40-mm on a sliding microtome in dry ice and stored at -
20°C in CPS.
Experiment III - Cholinergic Denervation Lesion
250g male Fischer-344 albino rats (n=13; Harlan Sprague-Dawley, Sulzfeld,
Germany) were anesthetized by an intramuscular injection consisting of 62.5-mg/kg
ketamine (Ketanest), 3.175-mg/kg xylazine (Rompun), and 0.625-mg/kg of
acepromazine maleate dissolved in 0.9% sterile saline. Rats were mounted in a small
animal stereotaxic apparatus (David Kopf, Tujunga, CA) with bregma and lambda in the
same horizontal plane.  A stainless steel cannula (10µl Hamilton syringe) was implanted
in the LV (AP +8 mm, ML -1.5 mm from the center of the interaural line in flat skull
position, DV +5.8 mm).  192IgG-saporin (5µl, 0.7 µg/ml, MAB390, dissolved in PBS) or
PBS (5µl) was injected at a flow rate of 1µl/min, resulting in a delivery of 3.5µg of toxin
into the LV. On days 3, 5 and 7 after infusion, animals received intraperitoneal injections
of bromodeoxyuridine (BrdU, 50mg/kg, Sigma, St. Louis, MO).  Four weeks after the
final BrdU injection, the animals were deeply anesthetized and intracardially perfused
with 4% PFA.  Brains were removed, post-fixed ON in 4% PFA/PB and transferred to
30% sucrose/PB.  The OBs were transected at the fornix level and cut sagitally in 40µm
sections on a sliding microtome in dry ice and stored at -20ºC in CPS.  The rest of the
brain was coronally cut at 40µm.
Experiment IV – Noradrenergic Denervation Lesion
Animals and tissue were treated the same as in Experiment III (n=12), with the
exception that 6 rats received 7.5µg (5µl) of mouse anti-DBH-SAP (MAB394) into the
same LV coordinates and the control group received PBS.  Injection flow rate was also
1µl/min.
Experiment V - Vascular endothelial growth factor induces neurogenesis in
the adult brain
Stainless steel cannulas, which were connected to osmotic minipumps (Model
2001, Alza) were implanted into two month old male Fischer-344 rats (n=36) according
to a previously established protocol 18. The animals received recombinant mouse VEGF-
A165 or aCSF, artificial cerebrospinal fluid, (n=18 each) at a flow rate of 1 µl/hr, resulting
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in a delivery of 2.4ng growth factor/day for 7 days.  During the last 6 days of the pump
period, animals received daily intraperitoneal injections of BrdU (50 mg/kg).  After 7 days
of ICV infusion, 8 animals per group were intracardially perfused with 4% PFA. The
remaining animals had the pumps removed and were perfused after an additional four-
week period without growth factor infusion.  Adult male rats were infused for 1 week with
recombinant mouse VEGF165 dissolved in artificial cerebrospinal fluid (aCSF) or aCSF
alone. During the infusion period, the animals received daily single intraperitoneal
injections of BrdU (50 mg/kg). In order to determine the number of cells that were
generated from dividing progenitor cells, 6 animals per group were perfused on the last
day of growth factor infusion. Four weeks after the infusion, the remaining rats (n=8 per
group) were perfused and this time point served to determine the survival rate and
neuronal differentiation of the newly generated cells. The animals were deeply
anesthetized with anesthetic cocktail and perfused transcardially with 4% PFA. The
brains were removed, post-fixed ON in 4% PFA/PB, and transferred to 30% sucrose/PB.
The brains were sagitally cut at 40-mm on a sliding microtome in dry ice and stored at -
20°C in CPS.
Experiment VI - Transient expression of doublecortin during adult
neurogenesis
Female Wistar rats (Charles River-Wiga, Sulzfeld, Germany) were kept in normal
light dark cycle (12 hour light/12 hour dark) and had free access to food and water.
Animals received at 2 months of age intraperitoneal injections of BrdU (50 mg/kg).
Animals perfused at 2 hours, 12 hours, 24 hours, 1, 2, 4 and 7 days after BrdU
treatment received only a single BrdU injection. The animals that were sacrificed at 10,
14, and 21 days, 1, 2, 3, 4, 6, 9, 14, and 19 months after BrdU injection received daily
injections on 4 consecutive days. Each time point consisted of 3 animals. At perfusion
time point, the animals were deeply anesthetized with a cocktail of ketamine,
acepromazine and xylazine and perfused transcardially with 4% PFA. The brains were
removed, post-fixed ON in 4% PFA/PB, and transferred to 30% sucrose/PB. The brains
were sagitally cut at 40-mm on a sliding microtome in dry ice and stored at -20°C in CPS.
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Histological Protocols
BrdU-DAB Protocol
Day 1
• Rinse 3x for 10 min in TBS
• 0.6% H2O2/TBS for 30 min
• Rinse 2x in TBS
• 50% formamide/2XSSC for 2hr at 65oC, shaking
• Rinse in 2XSSC for 5 min
• 2N HCl for 30 min at 37oC   Shake plate immediately after addition to avoid tissue clumping.
• 0.1M borate buffer pH8.5 for 10 min at RT
• Rinse 4x5 min in TBS
• Block: 3% donkey serum/0.1% TX100/TBS for 30 min
• Primary antibody in 3% donkey serum/0.1% TX100/TBS ON at 5°C
Day 2
• Rinse 2x10 min in TBS
• Secondary antibody in 3% donkey serum/0.1% TX100/TBS for 1 hr
*make ABP solution to allow mixture to equilibrate for at least 30 min
• Rinse 3x10 min in TBS
• Avidin-Biotin-Peroxidase (10µl/ml of A and B) for 1 hr
• Rinse 2x10 min in TBS
• DAB solution: 5-10 min
1 ml TBS
12.5 µl DAB (20 mg/ml)
0.3 µl H2O2 (30%)
16.67ml of 8% NiCl2
• Rinse 4x in tap water
• Rinse in TBS
• Mount
• Dehydrate through alcohol series, ending with NeoClear
• Coverslip with NeoMount
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BrdU Triple Immunofluoroscence Protocol
Day 1
• Rinse 3x for 10 min in TBS
• 50% Formamide/2xSSC for 2hr at 65°C, shaking
• Rinse in 2XSSC for 5 min
• 2N HCl for 30 min at 37°C  Shake plate immediately after addition to avoid tissue clumping.
• 0.1M borate buffer pH8.5 for 10 min at RT
• Rinse 4x5 min in TBS
• Block: 3% donkey serum/0.1% TX100/TBS for 30 min
• Primary antibody in 3% donkey serum/0.1% TX100/TBS ON at 5°C
e.g. rat anti-BrdU + mouse anti-NeuN + rabbit anti-S100b
Day 2 (following secondary antibody, all steps in dark)
• Rinse 2x10 min in TBS
• Secondary antibody in 3% donkey serum/0.1% TX100/TBS for 2 hr, RT, shaking
donkey anti-rat–FITC 1:1000
donkey anti-mouse-RHOX 1:1000
donkey anti-rabbit-CY5 1:1000
• Rinse 5x15 min in TBS
• Mount and coverslip
Immunofluoroscence Protocol
Day 1
• Rinse 3x for 10 min in TBS
• Block: 3% donkey serum/0.1% TX100/TBS for 30 min
• Primary antibody in 3% donkey serum/0.1% TX100/TBS ON at 5oC
e.g. rat anti-BrdU + mouse anti-NeuN + rabbit anti-S100b
Day 2 (following secondary antibody, all steps in dark)
• Rinse 2x10 min in TBS
• Secondary antibody in 3% donkey serum/0.1% TX100/TBS for 2 hr, RT, shaking
donkey anti-rat–FITC 1:1000
donkey anti-mouse-RHOX 1:1000
donkey anti-rabbit-CY5 1:1000
• Rinse 5x15 min in TBS
• Mount and coverslip
111
Standard TUNEL Protocol
• Rinse sections in TBS or PBS
• Rinse in H2O
• 50%, 70%, 96%, 100% isopropanol – 1 min each
• 100%, 96%, 70%, 50% isopropanol – 1 min each
• Rinse in H2O
• Rinse 3x in PBS – 5 min
All remaining steps in dark
• Equilibration Buffer (50µl/section) – 1 min, RT
• TdT Solution (50µl/section) – 1 hr, 37oC  (70µl reaction buffer + 30µl TdT Enzyme)
• Stop Buffer – 10 min, RT   (1:34, Stop concentrate:H2O)
• Rinse 3x in PBS – 5 min
• Secondary antibody: 1 hr, RT, shaking  (sheep anti-Dig–FITC 1:40 in PBS)
• Rinse 3x in PBS – 5 min
Can now do one of the following:
1. Mount and coverslip
2. Mount, follow with nuclear staining:
• propidium iodide 1:1000 (PBS), 5 min at RT in dark
• rinse 3x in PBS – 5 min
• coverslip
3. Block and continue with another fluorescent staining
TUNEL + Immunofluorescence Protocol
Day 1
• Standard TUNEL protocol to final rinse step
• Block: 3% donkey serum/TBS for 30 min
• Primary antibodies in 3% donkey serum/TBS ON at 5°C
e.g. mouse anti-NeuN + rabbit anti-s100b
Day 2
• Rinse 2x10 min in TBS
• Secondary antibody in 3% donkey serum/TBS for 2 hr at RT, shaking in the dark.
For example:
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donkey anti-sheep-FITC 1:1000 (for Tunel)
donkey anti-mouse-RHOX 1:1000 (for NeuN)
donkey anti-rabbit-CY5 1:1000 (for S100ß)
• Rinse 5x for 15 min in TBS (minimum), or ON at 5°C (no shaking!)
• Mount and coverslip
TUNEL + BrdU Protocol
Day 1
• Standard TUNEL protocol to final rinse step
• Fix: 4% paraformaldehyde in 0.1M PO4 for 20 min at RT
• Rinse 3x in PBS – 5 min
• 2N HCl for 30 min at 37°C   Shake plate immediately after addition to avoid tissue clumping.
• 0.1M borate buffer pH8.5 for 10 min at RT (brings pH back to neutral)
• Rinse 4x in TBS for 5 min (the more the better)
• Block: 3% donkey serum/TBS for 30 min
• Primary antibodies in 3% donkey serum/TBS ON at 5°C
e.g. rat anti-BrdU + mouse anti-NeuN
best results if primary antibodies incubate 2x ON (36 hr)
Day 2
• Rinse 3x for 5 min in TBS
• Secondary antibody in 3% donkey serum/TBS for 2 hr at RT, shaking in the dark.
For example:
donkey anti-sheep-FITC 1:1000 (for Tunel)
donkey anti-rat-RHOX 1:1000 (for BrdU)
donkey anti-mouse-CY5 1:1000 (for NeuN)
• Rinse 5x for 15 min in TBS (minimum), or ON at 5°C (no shaking!)
• Mount and coverslip
Nissl Staining
• Mount sections on gelatin-coated slides and let dry thoroughly
• De-fat in equal parts of chloroform/2-ETOH (100%) for 5 min
• Rehydrate as follows:
100% 2-propanol until clear (ª20 dips), repeat
95% 2-propanol until clear (ª20 dips), repeat
70% 2-propanol until clear (ª20 dips)
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50% 2-propanol until clear (ª20 dips)
• Rinse in deionized water 2X
• Stain in 1.5% cresylviolett 2 min  Note: heat to 60 degrees and filter before use.
• Rinse in deionized water 2X
• Rinse in tap water for 10 min
• Differentiate in 70% ETOH/0.5% acetic acid for a few seconds
• Rinse in tap water
If staining is too light, go back to Step 4 and repeat staining
• Dehydrate as follows:
70% 2-propanol until clear (ª20 dips)
95% 2-propanol until clear (ª20 dips), repeat 2X
100% 2-propanol until clear (ª20 dips), repeat 2X
NeoClear until clear (ª20 dips), repeat
• Coverslip with NeoMount.
DAPI/Propidium iodide Staining
• 1mg/ml stock solution
• Incubate sections/slides in 1:5000 solution for 10 min
• Wash 3X
• Coverslip
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Antibodies
Antibody Company Dilution
used
Primary Antibodies:
Goat anti-ChAT Chemicon, Temecula, CA 1:100
Goat anti-doublecortin C-18 Santa Cruz, Santa Cruz, CA 1:500
Mouse anti-ß-III Tubulin Promega, Madison, WI 1:500
Mouse anti-Nestin BD PharMingen, San Diego, CA 1:1000
Mouse anti-NeuN Chemicon, Temecula, CA 1:500
Rabbit anti-active Caspase-3 R&D Systems, Minneapolis, MN 1:1000
Rabbit anti-Ki-67 Jackson ImmunoResearch, West Grove, PA 1:500
Rabbit anti-Ki-67 Novacastra Laboratories Ltd., Newcastle
Upon Tyne, UK
1:500
Rabbit anti-S100ß Swant, Bellinzona, Switzerland 1:2500
Rat anti-BrdU Biozol, Eching, Germany 1:500
Rat anti-BrdU Accurate, Westbury, USA 1:500
Secondary Antibodies:
Donkey anti-goat-biotin Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-goat-FITC Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-goat-rhodamineX Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-mouse-biotin Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-mouse-CY5 Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-mouse-rhodamineX Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-mouse Alexa 488 Molecular Probes, Eugene, OR 1:300
Donkey anti-rabbit-CY5 Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-rabbit-FITC Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-rabbit-rhodamineX Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-rabbit Alexa 488 Molecular Probes, Eugene, OR 1:300
Donkey anti-rat-biotin Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-rat-CY5 Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-rat-FITC Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-rat rhodamineX Jackson ImmunoResearch, West Grove, PA 1:300
Donkey anti-rat Alexa 568 Molecular Probes, Eugene, OR 1:300
Donkey anti-sheep-FITC Jackson ImmunoResearch, West Grove, PA 1:300
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DNA Purification
Tails clippings from the mice were collected and processed with the DNeasy
Tissue Kit (QIAGEN) according to the manufacturer’s protocol.
PCR
To determine the genotype of the breedings, PCR analysis using 3 Primers (E2F1
5': GGA TAT GAT TCT TGG ACT TCT TGG (50µM), E2F1 3': CTA AAT CTG ACC ACC
AAA CGC (100µM), PGK-Neo 5' CAA GTG CCA GCG GGG CTG CTA AAG (50µM) and
the following PCR parameters were used: (1) 94°C 3 min, (2) 94°C 1 min, (3) 57°C 1
min, (4) 72°C 1 min, (5) repeat step (2)-(4) 30 times, (6) 72°C 10 min.
Quantities used:
12.5µl Master Mix
2µl E2F1-5’ primer
4µl E2F1-3’ primer
2µl E2F1-pgk primer
1µl DNA
3.5µl H2O
Stereology
For quantification, a systematic, random counting procedure, similar to the optical
disector342 was used as described by Williams and Rakic343. To determine the number of
Nissl- or DAPI-stained cells as well as BrdU-positive or TUNEL-positive cells in
individual brain regions, separate series of every 6th section (240 mm interval) of the left
hemisphere from each brain were analyzed. The volume of each structure was
determined by tracing the areas using a semi-automatic stereology system
(StereoInvestigator, MicroBrightField, Colchester, VT). Positive cells, which intersected
the uppermost focal plane (exclusion plane) and the lateral exclusion boundaries of the
counting frames, were not counted. As BrdU-labeled cells and TUNEL-labeled cells are
comparatively rare in the DG, no counting frames were used, but rather all cells in the
DG were counted on each section under exclusion of the uppermost focal plane.  In the
case of Experiment II (E2F), in order to calculate total cell counts in specific brain areas,
sections were counterstained with cresylviolet for Nissl-staining (Cerebellum and cortex)
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or with the fluorescent nuclear marker 4',6-diamidino-2-phenylindole (DAPI, DG and
SVZ).
To examine defined areas from free-floating sagittal sections several structures
were not analyzed in their entirety, but rather between selected anatomical landmarks
for reasons of reliability and reproducibility. Olfactory bulb (Figure 44B). For
stereological quantification the GCL, which continually incorporates new neurons, was
distinguished from the plexiform layer, which served as a control region. Lateral ventricle
wall (Figure 44C). All sections, where the LV formed an open cavity, were used for
analysis (between figure 82 and 89344). The rat stereotaxic atlas by Paxinos and
Watson344 was used as a reference for sagittal sections, because sagittal sections are
not available in the corresponding mouse atlas345. Dentate gyrus (Figure 44C). Cells
were counted in the molecular layer, the GCL and the hilus.  A series of every 6th section
was selected, starting where the dorsal DG separated from its ventral part (between
figure 88 and the midsagittal section344).
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Figure 44
Analysis of neurogenic regions. (A) Sagittal view of the mouse brain (modified, with permission of the
publisher, from Paxinos and Watson, 1998344) illustrates the anatomical sites of adult neurogenesis: the
olfactory bulb, the lateral ventricle wall, and the dentate gyrus. (B) For analysis, the olfactory bulb was
differentiated into separate layers, the granule cell layer (GCL) and the plexiform layer (PL), which was
defined as the area between the GCL and the glomerular layer (Glom). RMS—rostral migratory stream.
(C) The lateral ventricle wall (LV) adjacent to the striatum (Str) contains the proliferative subventricular
zone (SVZ). The ventricle wall was analyzed  (thick lines) from the ventral tip of the ventricle to the point
where the corpus callosum (CC) forms the roof of the ventricle. The dentate gyrus was separated into the
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granule cell layer (GCL), molecular layer (ML), and hilus region (Hil). CA1, CA2, CA3—cornu ammonis
regions 1–3; fi—fimbria fornix. (D) In order to obtain clearly defined areas for these three subregions, the
dorsal dentate gyrus (DG) was analyzed on all sections where it was separated from its ventral
counterpart.
Adaptations for specific experiments
Experiment II - Impaired adult neurogenesis in mice lacking the transcription
factor E2F1
Cerebellum and neocortex. Nissl-stained series of every 6th sagittal sections were
used to determine number of neurons in the cerebellum and neocortex. The cerebellum
was analyzed on sections that included the lateral or the medial cerebellar nucleus as a
landmark (between figures 80 and 86344). A counting frame size of 20x20 µm and a grid
of 750x750 µm to space the count frames systematically across the cerebellum resulted
in the detection of more than 700 granule cells per animal. To determine the volume and
the number of neurons in the neocortex, sections were selected that included the
capsula interna as an external landmark344. On these sections the neocortex was
analyzed in its entire depth (layer I-VI) and length (from the rhinal fissue to the occipital
pole). In order to estimate the total number of cortical neurons a counting frame size of
30x30 µm and a grid of 300x1200µm was used, leading to the detection of more than
500 neurons per animal. In order to determine the fraction of BrdU-positive cells among
the total population of cells, DAPI-positive cells were stereologically counted in the GCL
of the DG (counting frame size of 20x20 µm and a grid of 120x120µm) and the SVZ
(counting frame size of 30x30 µm and a grid of 100x100µm). The resulting cell number
was used to calculate the percentage of BrdU-positive cells relative to the total number
of cells.
Experiment IV – Cholinergic Denervation Lesion
Although the lesion was bilateral, since the toxin was administered through the LV,
the ipsilateral side was nevertheless used for analysis. To determine the number of
BrdU-positive or TUNEL-positive cells in the OB, separate series of every 4th section
(160-µm interval) were analyzed.  A counting frame of 40 x 40-µm and a grid size of
350x350 µm were used for analysis of BrdU.  TUNEL-positive cells in the OB were
counted exhaustively.
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Experiment V - Vascular endothelial growth factor induces neurogenesis in
the adult brain
For the LV, counting frame and sampling grid sizes of 20x20 µm and 50x100 µm
and for the OB 60x60 µm and 300x300 µm were used.
Microscopy
Fluorescent signals were detected using a confocal scanning laser microscope
(Leica TCS-NT, Leica Lasertechnik, Heidelberg, Germany) and a 40xPL APO oil
objective (1.25 NA). To avoid cross detection of FITC signals in the rhodamine channel
and Rhodamine-X detection in the CY-5 channel, the fluorescent images were
sequentially recorded for each channel with only the corresponding single wavelength
laser line (488 nm, 568 nm or 647 nm) activated using acusto-optical tunable filters. In
order to exclude false-positive signals from overlying cells, pinhole settings were used
that corresponded to an optical thickness of less than 2 µm.  Randomly selected BrdU-
positive cells were analyzed in their entire z-axis in order to exclude false double-
labeling due to an overlay of signals from different cells18. A minimum of 50 BrdU-
positive cells per region of interest were examined for co-labeling in each animal and
time point.
Neuronal differentiation
To determine the percentage of differentiation of newborn cells, a series of every 6th
section was stained for double immunofluorescence using antibodies against BrdU,
NeuN, S100ß, etc. For each brain and each neurogenic region, 50 BrdU-positive cells
were randomly selected and analyzed for double labeling with BrdU. The resulting
percentages for each group were multiplied with the stereologically estimated numbers
of BrdU-positive cells in order to estimate the number of newly generated neurons,
astrocoytes, etc.
Statistical analysis
The data are expressed as mean values +/- standard error of mean (S.E.M.)
Statistical analysis was performed using the unpaired, two-sided t-test comparison
(Student’s t-test) (Statview, SAS Institute, Cary, NC). Significant differences were
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assumed at a level of p < 0.05.  The data are expressed as mean values +/- standard
error of mean.
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Chemicals
ABC Kit (avidin-biotin-peroxidase complex; Vectastain Elite, Vector Laboratories,
Burlingame, CA, USA)
1M Acetic Acid
6ml Glacial Acetic acid
QS to 100ml
1% Agarose Gel, 100ml
1g agarose
6µl 10mg/ml ethidium bromide
Anesthesia Cocktail:
62.5mg/kg ketamine (Ketanest)
3.175mg/kg xylazine (Rompun)
0.625mg/kg acepromazine maleate
dissolve in 0.9% sterile saline
Apoptag In Situ Cell Death Detection Kit (Intergene, Purchase, NY)
Borate Buffer (0.5M Stock) ph 8.5
15.45g boric acid
450ml H20
5ml 10N NaOH (to bring pH to 8.5)
QS to 500ml
10X Blue Juice (10ml)
5ml Glycerin
2ml 100mM EDTA, pH 8.0
25mg 0.25% bromophenoblue
25mg 0.25% xylenecyanol
3ml H2O
BrdU
Dissolve in sterile NaCl
Mouse – 10mg/ml
Rat – 20mg/ml
CPS – Cryoprotection Solution (1 liter), store at RT
250ml Glycerin
250ml Ethylene glycol
500ml 0.1M PO4
Cresyl Violet (Nissl Staining)
1.5g Cresyl Violet
98ml H2O
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1ml 1M CH3COOH
1ml 1M Sodium acetate
aCSF (artificial CSF), pH 7.2
8.65g NaCl
0.22g KCl
0.21g CaCl2•2H2O
0.16g MgCl2•6H2O
0.21g Na2HPO4
0.03g NaH2PO4•H2O
QS to 1 liter with H2O, sterile filter
DAB
20mg/ml in H2O
DAPI (4’,6-diamidino-2-phenylindole)
DNA Molecular Weight Marker VIII (Roche Diagnostics, Mannheim, Germany)
Dneasy Tissue Kit (QIAGEN, Hilden, Germany)
Formamide Deionisation
4 large spoonfuls of Resin in 1 liter of Formamide; stir 1 hour.  Filter and freeze.
HCL 5N
[HCl] = 11.6M
43ml concentrated HCl
57ml H20
Master Mix for PCR (QIAGEN, Hilden, Germany)
4% Paraformaldehyde (1liter)
40g paraformaldehyde
0.5l H2O
1ml 10N NaOH, stir until clear
Filter into larger vessel
Filter 0.5l 0.2M PO4 into same vessel
10X PBS, pH 7.4 – Ca2+, Mg2+-free (Dulbecco’s)
40g NaCl
1g 1KCl
7.2g Na2HPO4•2H2O (or 5.4g Na2HPO4 water free)
1g KH2PO4 (water free)
QS to 500ml with H2O
Phosphate buffer (PO4)
0.2M PO4 from water-free Natriumphosphate:
1 Liter dH2O
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5.52g Sodium-dihydrogen-phosphate (NaH2PO4 water free)
21.9g Disodium-hydrogen-phosphate (Na2HPO4 water free)
OR
0.2M PO4 from water-based Natriumphosphate:
1 Liter dH2O
6.35g Sodium-dihydrogen-phosphate monohydrate (NaH2PO4 x H2O)
41.35g Disodium-hydrogen-phosphate heptahydrate (Na2HPO4 x 7 H2O)
0.1M Phosphate Buffered Saline (PBS)
500ml 0.2M PO4
500ml dH2O
9g Sodium chloride
Propidium iodide
ProLong (Molecular Probes, Eugene, Oregon, USA)
30% Saccharose (500ml)
400ml 0.1M PO4
150g Saccharose
store at +5oC
1M Sodium Acetate
82.03g
QS to 1 liter
20X SSC, pH 7.0
3.0M NaCl 86.65g
0.3M NaCi x 2H20 44.1g
QS to 500ml
ToPro-3 (1:2500; Molecular Probes, Eugene, OR)
Tris Buffered Saline (TBS)
870ml dH2O
100ml 1M Tris-HCl pH7.5
30ml 5M NaCl
10X TBS (1l), pH 2.4-2.5, store at +5oC
855ml dH2O
132.2g Trizma HCl
19.4g Trizma Base
90g NaCl
TBS++
TBS buffer
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0.1% Triton-X100
3% donkey serum
TdT-Enzyme (from Apoptag Kit)
TUNEL Dilution Buffer (Roche Diagnostics, Mannheim, Germany)
TUNEL-Reaction Buffer (from Apoptag Kit)
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APPENDIX
Table I
Interventions influencing Proliferation in Dentate gyrus
Up-regulate Down-regulate
Adrenalectomy104, 105, 108 Prenatal stress106, 107
NMDA blockers117-120 Predator-odor exposure stress,
rats103
Ovarian steroids - estrogen346-348 Acute psychosocial stress, tree
shrew72, 102
HB-EGF, ICV349 Resident-intruder stress, monkeys73
Lithium350 Alpha-tocopherol351
Fetal raphe grafts into hippocampus after
5,7-DHT lesion214
Glucocorticoids - corticosterone104,
108
Entorhinal cortex leions117 Ovariectomy348
Haloperidol, gerbils352 NMDA117
Focal ischemia, rat142, 340, 353 5,7-DHT lesion into medial and
dorsal raphe214
Transient focal ischemia, gerbil354, 355 Acute methamphetamine356, 357
Global ischemia, gerbil358 NMDA blockers following focal
ischemia, rat121, 353
Cerebral ischemia349 Electromagnetic exposure, gerbil359
Kainic acid333 Irradiation163, 360
Caspase inhibitors following status
epilepticus361
Stretozotocin-induced diabetes362
Traumatic brain injury324, 325 CREB-/- transgenic mice287
mCD24-/- transgenic mice363
Strain variations364, 365
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Interventions influencing Neurogenesis in Dentate gyrus
Up-regulate Down-regulate
Enriched environment60, 90-92 Corticosterone109
Enriched environment in aged animals38,
264
Minera locor t ico id receptor
knockout mice366
Running95, 96 PCPA348, 367
Dietary restriction368, 369 Nicotine370
Dehydroepiandrosterone,
subcutaneous109
Cortical contusion327
FGF-2, subcutaneous114 Irradiation371
IGF-1, peripheral115 Presenilin-1 knockout mice had
no ef fect  wi th enr iched
environment372
IGF-1, ICV in aged animals116 IL-6, transgene373
VEGF299 E2F1-knockout mice374
Chronic antidepressant treatment375
Transient global ischemia, gerbil/rat337,
338
Seizures21, 332-335
Electro-convulsive shock seizures376, 377
Traumatic brain injury326
Mossy fiber stimulation, LTP378
Rol ipram, inh ib i tor  o f  cAMP
breakdown287
Overexpression of wildtype presenilin-
1379
127
Interventions influencing Proliferation in SVZ
Up-regulate Down-regulate
Estrogen, prarie vole380 TGF-a knockout mice381
HB-EGF, ICV349 Irradiation136
Focal ischemia, rat142) Erythropoietin, ICV382
Prolonged seizures336 Amyloid beta-peptide, ICV383
Atypical neuroleptics384
Traumatic brain injury325
OB ablation385, 386
N-acetyl cystein387
Anti-erythropoietin antibody, ICV382
Infusion of ectodomain of either EphB2
or ephrin-B2388
p27Kip1 knockout mice318
mCD24 knockout mice363
Interventions influencing Neurogenesis in Olfactory Bulb
Up-regulate Down-regulate
Enriched odor exposure94 EGF, ICV18
FGF-2, ICV18 Nasal plug12
FGF-2, subcutaneous114 ZnSO4 intranasal perfusion389
BDNF, ICV320 Anti-erythropoietin antibody, ICV382
Adenoviral BDNF overexpression of
SVZ cells319
E2F1 knockout mice374
Erythropoietin, ICV382
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